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ABSTRACT

The New York City Childcare Influenza Vaccine Mandate: A Case Study
by
Amy Metroka

Advisor: Betty Wolder Levin, PhD

Background. In 2014, New York City (NYC) became the third jurisdiction in the United States
(US) to enact a childcare influenza vaccine mandate, after the states of New Jersey and
Connecticut. The mandate was enacted by the NYC Board of Health by amending the NYC
Health Code. The mandate’s goal was to increase vaccination rates among 6-59-month-olds
attending city-regulated public and private childcare programs, including prekindergarten, to
protect children, families, and the community against influenza. Children younger than 5 years
are at high risk for severe illness and complications from influenza. Children are also known to
be a major source of influenza transmission in communities. The mandate covered an estimated
122,430 children, representing approximately 24% (122,430/508,112) of all 6-59-month-olds in
NYC. Five mothers brought a lawsuit against the mandate in November, 2015. In response, the
New York State Supreme Court suspended the mandate in mid-December, 2015, in a ruling
stating the NYC Board of Health did not have the authority to require a vaccine not authorized
under state law. NYC appealed, but the suspension was upheld by the State Supreme Court,
Appellate Division, in October, 2016. This court ruled that the NYC Board of Health had the
authority to require the vaccine, but upheld the suspension because the mandate applied to city-

iii

regulated childcare, not all childcare in NYC, and, in their opinion, it wrongly allowed childcare
programs to opt out of excluding noncompliant children by paying fines. NYC is preparing a
second appeal and is also continuing to advocate for the New York State Legislature to add the
childcare influenza vaccine requirement by changing state law.
Objectives. This study had two aims. Aim 1 was to analyze the rationale and ethics of the
mandate. The decision to mandate a childhood vaccine requires careful consideration because it
infringes upon parental autonomy and can generate controversy that may undermine public
acceptance of vaccines in general. Aim 2 was to assess the mandate’s effect on influenza
vaccination rates among 6-59-month-olds citywide. The findings were intended to guide future
decisions to enact childhood vaccine mandates.
Methods. This research followed a convergent mixed methods study design in which qualitative
and quantitative methods were used complementarily. A single-case study with record review
was used to achieve Aim 1, along with an application of the Kass, and Field and Caplan
conceptual frameworks to analyze the mandate’s ethics. For Aim 2, a short, interrupted timeseries method was used to examine influenza vaccination rates among 6-59-month-olds as of
December 31 in 8 annual influenza seasons before the mandate (2006-07 through 2013-14), 2
seasons during the mandate (2014-15 through 2015-16), and one season after the mandate’s
suspension (2016-17). Vaccination rates were also assessed among a control group of 5-8-yearolds and among the aggregate groups of 6-59-month-olds and 5-8- year-olds stratified by oneyear age groups.
Results. NYC gathered and analyzed scientific evidence, reached out to community partners,
and deliberated for nearly one year before deciding to seek enactment of the mandate by the
NYC Board of Health. The decision was reached only after advocacy to add the childcare
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influenza vaccine requirement by changing state law was unsuccessful. The time-series analysis
of vaccination rates showed the mandate had little impact on rates among the aggregate group of
6-59-month-olds. Among 4-year-olds, however, vaccination rates increased 11.4 percentage
points, by far the largest increase among all age groups. The vaccination rate dropped by 12.1
percentage points among 4-year-olds after the mandate was suspended.
Conclusions. The rationale for the mandate was strong based on evidence of the health and
economic burden of influenza, increased vaccination rates reported by New Jersey and
Connecticut, and the support of pediatricians, nurses, and pro-vaccine parents. Application of the
Kass framework found the mandate ethical because it was enacted through a democratic process,
applied to all 6-59-month-olds attending city-regulated childcare and prekindergarten, allowed
for legitimate medical or religious exemptions, and was effective in raising vaccination rates
among 4-year-olds. Based on the Field and Caplan framework, the mandate was ethical because
NYC’s obligation for utilitarianism, beneficence, justice and nonmaleficence took precedence
over parental autonomy in the context of the potentially severe disease of influenza. Despite the
mandate’s suspension and subsequent loss of gains realized in raising vaccination rates, NYC
was able to demonstrate the mandate’s success at increasing influenza vaccine uptake among
4-year-olds, the largest age group in childcare and prekindergarten. This evidence offers strong
support for a change in state law to implement the childcare influenza vaccine requirement
statewide. In the absence of such a change, alternatives to a mandate for increasing influenza
vaccination rates among young children in NYC are needed.
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Section 1: Introduction and Background
The New York City Childcare Influenza Vaccine Mandate
In 2014, New York City (NYC) became only the third jurisdiction in the United States (US)
to enact a childcare influenza vaccine mandate, after the states of New Jersey and Connecticut.1-2
The mandate was enacted by the NYC Board of Health, at the urging of the NYC Department of
Health and Mental Hygiene (DOHMH). The NYC Board of Health amended the NYC Health
Code to add influenza vaccine to the list of vaccines required for city regulated public and
private childcare programs for children younger than 6 years of age, including prekindergarten.
The mandate’s goal was to increase influenza vaccination rates among young children to protect
individual children, their families, and the community against the highly contagious and
potentially deadly disease of influenza. The mandate required children 6-59 months of age
attending childcare to receive 1 dose of influenza vaccine between July 1 and December 31 of
each year starting July 1, 2014.3 The mandate covered approximately 122,430 children,
representing an estimated 24% (122,430/508,112) of all NYC children 6-59 months of age.4-6
In November, 2015, five mothers brought a lawsuit against the mandate.7 In response, the
New York State Supreme Court suspended the mandate on December 16, 2015, in a ruling
stating that the NYC Board of Health did not have the authority to require a vaccine that is not
authorized under state law.8-9 The NYC Law Department appealed the decision in June, 2016,
but the State Supreme Court, Appellate Division, upheld the suspension in a decision announced
in October 2016.10 This court found that the NYC Board of Health had the authority to mandate
the vaccine, but upheld the suspension because the mandate applied to only city-regulated
childcare, not to state-regulated childcare in NYC as well, and, in their opinion, allowed
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childcare operators to buy their way out of excluding noncompliant children by paying fines.10
The NYC DOHMH and NYC Law Department are preparing a second appeal. The NYC
DOHMH has also continued to advocate for the New York State Legislature to amend state law
to add the childcare influenza vaccine requirement. The NYC DOHMH had advocated for a state
law change in 2013 before seeking the amendment to the NYC Health Code but the proposal did
not move forward. A bill to change state law to enact the childcare influenza vaccine mandate
was introduced in May 2017.11 The chances of its passage are unknown at this time.
The purpose of this study was to examine the rationale and ethics of the NYC DOHMH
decision to ask the NYC Board of Health to enact the childcare influenza vaccine mandate, and
to evaluate the mandate’s effect on influenza vaccination rates among NYC children 6-59
months of age. Because vaccine mandates affecting children infringe upon parental autonomy,
they raise ethical questions and often generate controversy. Public health professionals recognize
that such controversy could result in public backlash against vaccines in general. Consequently,
the decision to mandate a particular vaccine requires careful deliberation and consideration of
alternatives for increasing vaccine uptake.
Public Health Significance of Influenza
Preschool-age children are at high risk of severe illness and complications from influenza.
Among children younger than 2 years of age, hospitalization rates for influenza are comparable
to those for people 65 years of age and older.12-13 Annual hospitalization rates for laboratoryconfirmed influenza among children 6 months of age or younger range from 240 to 720 per
100,000 children. Among children 2-5 years of age, these rates are approximately 20 per
100,000. Among children younger than 5 years of age with high-risk medical conditions,
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hospitalization rates for laboratory-confirmed influenza climb to approximately 250 to 500 per
100,000.13 Children 24-59 months of age have a lower risk of hospitalization from influenza but
have a greater risk of influenza-associated visits to clinics and emergency departments.12-13
Moreover, children are a major source of influenza transmission within communities.12-14
Congregate settings such as childcare programs and schools facilitate the spread of highly
infectious diseases including influenza.14 Among the general population in the US, influenza is
associated with an average of over 200,000 hospitalizations annually.12-13 Influenza-related
deaths vary substantially by year depending on the types of influenza viruses circulating during
the season. From 1976-2007, estimates of influenza-associated deaths ranged from a low of
3,349 in 1986-87 to a high of 48,614 in 2003-04.12, 15
Gaps in the Literature
Strong evidence supports vaccine mandates as effective interventions for raising vaccination
coverage rates among children attending childcare and school. A large body of research has
shown that childcare and school entry vaccine requirements are successful at achieving and
maintaining high vaccination rates and low rates of vaccine-preventable diseases and associated
morbidity and mortality.16-19 However, some studies suggest that childcare vaccine mandates are
not always effective at increasing vaccination rates.20-21 This study adds new evidence on the
effectiveness of childcare vaccine mandates by evaluating the impact of the NYC mandate on
influenza vaccination rates among children 6-59 months of age.
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Study Innovation
This was the first study to examine a childcare influenza vaccine mandate enacted through a
city health code change, in contrast to the state policy-making process used by New Jersey and
Connecticut. This difference had implications for enforcement of the NYC mandate, and was
also the grounds for the New York State Supreme Court decision to suspend NYC’s mandate.8-9
Colgrove and colleagues (2010) pointed out the limitations of a state legislative process for
mandating vaccines, which would have been necessary for a statewide childcare influenza
vaccine requirement in New York. These authors suggested using an administrative process,
such as a health code change enacted by a Board of Health, as a preferred approach to passing a
state law because it may be less vulnerable to political influences and more likely to be grounded
in scientific evidence.22 This study examines the strengths and limitations of adding a vaccine
requirement through a city health code change as well as other factors that influenced the
enactment of NYC’s mandate.
Conceptual Frameworks
This study was guided by the Kass framework for an ethics analysis of public health
interventions (2001) 23 and the Field and Caplan ethical framework for vaccine mandates
(2008).24 The Kass framework is meant to help public health practitioners promote public health
goals while increasing individual liberties and social justice to the extent possible. Kass’s
framework calls for answers to the following six questions. These questions will first be adapted
to evaluate the ethics of vaccine mandates in general, and then used a second time to analyze the
ethics of the NYC childcare influenza vaccine mandate specifically. Question 2 in the framework
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will be informed by a quantitative analysis of influenza vaccination rates among 6-59-montholds before, during, and after the mandate.
1. What are the public health goals of the proposed program?
2. How effective is the program in achieving its stated goals?
3. What are the known or potential burdens of the program?
4. Can burdens be minimized? Are there alternative approaches?
5. Is the program implemented fairly?
6. How can the benefits and burdens of a program be fairly balanced?
The Field and Caplan framework is based on the concept of balancing the competing values
of autonomy and beneficence in the context of disease severity, as illustrated by their graphic
illustration (Diagram 1, page 7).24 This study applies the framework, which also includes the
values of utilitarianism, justice, and nonmaleficence, to assess the ethical balance represented by
the NYC childcare influenza vaccine mandate.
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Specific Aims
This study included two specific aims:
Aim 1. Analyze the Rationale and Ethics of NYC’s Childcare Influenza Vaccine Mandate
This aim was achieved by developing a single-case study based on record review including a
NYC DOHMH briefing and presentations, NYC Board of Health documents, court documents,
media reports, and publications.
Aim 2. Evaluate the Effect of the NYC Childcare Influenza Vaccine Mandate on Influenza
Vaccination Rates among 6-59-Month-Old Children Citywide
This aim was achieved by conducting a quantitative analysis of the mandate’s impact on
influenza vaccination rates among 6-59-month-olds, the age group directly affected by the
mandate, compared to 5-8-year-olds, an age group also recommended to receive influenza
vaccine but not covered by the mandate.

6

Diagram 1. Autonomy vs. Beneficence (Field and Caplan 2008)
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Section 2: Literature Review
Childhood Vaccine Mandates
Purpose. Children in congregate settings such as childcare programs, preschools, and
elementary through high schools are at risk of acquiring and spreading diseases transmitted
through casual contact.14 Many of these diseases are preventable with vaccines. One of public
health’s greatest achievements, vaccines are credited with dramatically reducing morbidity and
mortality from diseases such as polio, measles, and pertussis.16, 25 In the US from 1924 to 2012,
an estimated 100 million cases of disease were prevented by vaccines, with only rare serious side
effects.26-28 The purpose of childhood vaccine mandates is to achieve high vaccination rates
among preschool- and school-age children to protect individual children and their families, as
well as the community, from vaccine-preventable diseases.16-17, 19
History. The first vaccine mandate in the US was a state law enacted in Massachusetts in
1809 to require children and adults to be vaccinated against smallpox to control outbreaks of the
disease.17, 29 In 1827, Boston became the first municipality to require children entering public
schools to be vaccinated. In 1855, Massachusetts became the first state to pass a compulsory
school vaccination law. Since then, immunization laws have remained state-based; there is no
national immunization law.17-18, 30 Today, all 50 states have laws requiring children to be
vaccinated against a range of diseases to attend childcare and schools.31-32 Medical exemptions
from vaccination requirements are allowed in all 50 states and the District of Columbia (DC). As
of 2016, religious exemptions are allowed in 46 states and DC, and 19 states allowed
philosophical or personal belief exemptions.33 In New York State, medical and religious
exemptions are allowed but not personal belief exemptions. Mississippi, West Virginia, and
California were the only states to allow only medical exemptions, i.e., no exemptions for
8

religious or personal beliefs are permitted by these states.33 California eliminated nonmedical
exemptions recently in response to the highly publicized 2015 Disneyland measles outbreak.27
Vaccines Required. The number and types of vaccines required for childcare,
prekindergarten, and school attendance may vary by state or local jurisdiction. In NYC, a child
attending licensed childcare or prekindergarten in 2016-2017 is required to receive the following
vaccines: 4 doses of diphtheria and tetanus toxoids and pertussis (DTaP), 1 dose of measlesmumps-rubella (MMR), 3 doses of Hepatitis B, 1 dose of varicella, 3 doses of polio, 1 to 4 doses
of Haemophilus influenzae type B (depends on age and vaccine doses previously received), and
1 to 4 doses of pneumococcal conjugate (depends on age and vaccine doses previously
received).34 The requirements are the same for children in the rest of New York State.35
Influenza vaccine was required for NYC children attending city-regulated childcare and
prekindergarten during the 2014-15 and 2015-16 school years.1-3, 9-10
Enforcement. In most states, including New York, childcare and schools are obligated to ask
parents to produce documentation of the child’s vaccination history or to obtain an exemption.
Children may be admitted on a provisional basis if the child has received some but not all doses
of mandated vaccines. Provisionally admitted children are required to follow an official catch-up
immunization schedule to reach full compliance.36 Childcare operators are required to exclude
noncompliant children from their programs. School principals are required to exclude
noncompliant children in grades kindergarten through 12. The state and/or local health
departments enforce compliance with immunization requirements in childcare and schools by
regularly reviewing a sample of or all enrollee vaccination records to identify noncompliant
children. The health departments can issue a notice of violation, which can lead to a substantial
fine, when a childcare operator or principal is found to fail to exclude noncompliant children.
9

Enforcement of exclusion may be uneven, however, and may vary by childcare program, school
principal, and health department.17, 20, 30
Exemptions. In some states and local jurisdictions, the process for obtaining an exemption
from required vaccines for a child attending childcare or school may simply require a parent
signature on a form.31-32 In others, such as NYC, the request is reviewed to determine the validity
of a medical condition or that the parent has demonstrated sincerely held religious beliefs against
vaccination.37 Studies have shown that states which easily grant exemptions have higher
nonmedical exemption rates and increased incidence of vaccine-preventable disease.31-32
In NYC, parents requesting a religious exemption for a child in public school must provide a
letter explaining the foundation of their religious beliefs opposing immunization. This letter must
be submitted to the school principal’s office. It is then forwarded to the Office of School Health
(OSH), which is run jointly by the NYC Departments of Education and Health and Mental
Hygiene. OSH personnel review the letter to determine whether to approve or deny the
exemption.37 An estimated 77% of religious exemption requests are approved.38 Despite this
high approval rate, religious exemption rates in NYC public schools are very low. As of the end
of the 2015-16 school year, among NYC public school children <18 years, a population of nearly
1.1 million students, only 0.21% had a religious exemption.39
Medical exemption requests for NYC public school students necessitate a letter or completed
form from a New York State licensed physician certifying that one or more of the vaccines
required are detrimental to the child’s health, and for how long the vaccinations should be
deferred.37 OSH also reviews these requests and may approve or deny them. Data were not found
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on the proportion of medical exemptions approved. The medical exemption rate was 0.02%
among all NYC public school children at the end of the 2015-16 school year.39
There is no standard process for parents to apply for a religious or medical exemption from
NYC non-public schools and childcare. Non-public schools and childcare programs decide on
their own procedures but may consult the NYC DOHMH Bureau of Immunization for guidance.
Based on self-reported data on the annual immunization compliance survey required by New
York State, the NYC non-public schools had a medical exemption rate of 0.1% and a religious
exemption rate of 0.6% for the 2013-14 school year. For the same year and data source, NYC
regulated childcare had a rate of 0.1% for medical and 0.4% for religious exemptions. State
regulated group family day care programs in NYC had a rate of 0.0% for medical and 0.3% for
religious exemptions based on the New York State survey that same year.4
Controversy. Vaccine mandates have generated controversy since the 1800s.40 Numerous
legal challenges have been mounted against them but courts have mostly upheld vaccine
mandates. A landmark case was Jacobson versus Massachusetts in 1905, brought by a man who
refused smallpox vaccine. The US Supreme Court ruled against Jacobson, endorsing the rights of
states to pass and enforce compulsory vaccination laws.16, 30 In 1922, in a case brought on behalf
of a girl excluded from school in Texas, the US Supreme Court found school vaccination
requirements to be constitutional. Subsequent cases have reaffirmed this decision.16, 30 A federal
appeals court recently upheld New York State’s authority to exclude unvaccinated children from
school during disease outbreaks, including those from families with an approved religious
exemption.41
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Critics view vaccine mandates as government infringement on parental autonomy.40-42
Childhood vaccine mandates captured the attention of candidates for the 2016 presidential
election. Responding to stepped up efforts by states to vaccinate or exclude school children to
control a multi-state measles outbreak, Rand Paul commented “The state doesn’t own your
children, parents do.” 27
Ethics. Childhood vaccine mandates limit parental autonomy and may understandably be
seen as coercive. A legitimate question is, then, whether they are ethical. To consider this
question, the Kass six-step framework for an ethics analysis of public health programs 23 is
applied to childhood vaccine mandates.
1. What are the public health goals of childhood vaccine mandates? Vaccine mandates are
intended to protect individual children and the community from serious illness or death by
vaccinating the majority of preschool- and school-aged children against vaccine-preventable
diseases.16-17, 19 Vaccine effectiveness relies on herd immunity, reached only after a critical mass
of people in a community develop immunity so that a disease will be prevented from spreading
because of the low probability that an infected person will encounter a susceptible person.31-32
Herd immunity protects infants too young to be vaccinated, people who cannot be vaccinated
because their immune systems are compromised by cancer or other chronic disease, people who
do not mount an adequate immune response to vaccine or whose immunity wanes over time,
individuals who choose not to be vaccinated, and children whose parents refuse vaccines.30-31
The proportion of individuals who must be vaccinated to prevent community transmission
varies by infectiousness of the disease and other conditions, but it is generally between 75% and
95%.16, 30-31 Because of the need for herd immunity, a parent’s decision to accept vaccine for
their child may not only affect their child’s health but also that of people in the community. This
12

tension between individual rights and the responsibility to protect others is at the heart of vaccine
policy ethical considerations.42 Those who believe that the rights of communities to avoid
potentially life-threatening diseases outweigh an individual’s right to refuse vaccines will likely
find vaccine mandates to be ethical.
2. How effective are childhood vaccine mandates in achieving their goals? Research has
shown that childcare and school entry vaccine requirements are effective at achieving and
maintaining high vaccination rates and low rates of vaccine-preventable diseases and associated
morbidity and mortality.16-18 Based on a systematic review, the US Task Force on Community
Preventive Services recommended vaccination requirements for childcare and school attendance
as an evidence-based public health intervention for increasing vaccination rates and decreasing
morbidity and mortality resulting from vaccine-preventable diseases.19
Some studies, however, have found that childcare vaccination requirements are not always
effective at raising vaccination rates. A national study by Stanwyck and colleagues (2004) found
no significant difference in up-to-date vaccination rates between children in and not in childcare
(73.1% versus 71.9%) at age 24 months.20 The authors suggested these findings may be due to a
lack of standard assessment and enforcement of vaccine policies among childcare facilities. They
called for implementation of standards modeled on states demonstrating success at achieving
high compliance.20
Kolasa and colleagues (2003) conducted a study of nearly 3,000 children younger than 5
years of age attending childcare centers in Philadelphia.21 They saw no significant increase in
vaccination rates between the date children enrolled and 60 days later, when state law required
the children to be up-to-date on mandated vaccines to remain in childcare. Among children 1935 months, 72% were up-to-date at enrollment compared to75% after 60 days.21 However, a
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limitation of this study may have been that the 60-day period for reaching up-to-date status was
too short for children who were far behind on vaccines requiring multiple doses. For example, to
be considered up-to-date for DTaP, a child would need 4 doses with each dose separated by at
least 4 weeks (doses 1 to 2) or 6 months (doses 3 to 4).36
3. What are the known or potential burdens of childhood vaccine mandates? The main
burdens of vaccine mandates on the public are: (1) curtailment of parental autonomy;
(2) exposing children to health risks from vaccines; (3) costs, both monetary and time spent, that
must be borne by parents to assure children receive multiple vaccinations over a series of visits
to medical providers or to comply with administrative procedures for obtaining an exemption.
Costs are also borne by the general public to support enforcement of vaccine mandates by public
health entities as well as by childcare and prekindergarten personnel to promote and monitor
compliance of enrolled children.
The burdens associated with childhood vaccine mandates are further described below.
4. Can the burdens of childhood vaccine mandates be minimized?
(1) Autonomy. Some parents argue that the decision to vaccinate their child rests with the
parent alone, and that the parent should be able to opt out of a vaccine mandate should they wish
to do so. To some degree, the burden of limiting parental autonomy is reduced by allowing for
medical, religious, or personal belief exemptions. Medical exemptions must be allowed per the
US Supreme Court’s ruling in the 1905 Jacobson case that states may compel vaccination to
control disease but may not jeopardize the health or life of an individual.29 Religious or personal
belief exemptions are not constitutionally required.27, 44 Many states allow nonmedical
exemptions, however, to limit the perception of state coercion.45
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Personal belief exemptions are a topic of hot debate. Some public health leaders argue for
their elimination because they threaten herd immunity while others want to maintain personal
belief exemptions to avoid public backlash.45-46 Public health leaders agree that caution must be
exercised to ensure that exemption application procedures lead to approval of only those for
individuals demonstrating sincerely held beliefs. States with simple applications for nonmedical
exemptions have had high exemption rates and associated disease outbreaks due to clustering of
exempted children.32, 47 Washington State recently added a requirement to the nonmedical
exemption application that parents must receive education from a medical provider. The purpose
was to increase parents’ understanding of vaccine benefits and risks and to discourage those who
would seek an exemption out of convenience.45
Most pediatricians have encountered families deciding to delay or decline vaccination.
Periodic surveys conducted by the American Academy of Pediatrics (AAP) show that 7 of 10
pediatricians report having had a parent refuse a vaccine for a child within the 12-month period
before completing the survey.48 These physicians are faced with the ethical dilemma of whether
to respect the parent’s autonomy, even though the physician believes vaccination is in the best
interests of the child and community, or to decline to serve as the child’s physician. The AAP
offers the general recommendation to avoid discharging a patient solely for refusal of the parent
to have the child vaccinated.48 Evidence suggests most parents who choose not to follow the
recommended vaccine schedule are able to get access to physicians who will maintain the
physician-patient relationship.49
Some pediatricians, however, have decided to inform new families they will not be able to
offer care if the family chooses to delay or refuse most vaccines. They cite several reasons: 1) to
avoid exposing patients to unvaccinated individuals in waiting rooms, with the possibility of
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transmitting highly infectious vaccine-preventable diseases such as measles; 2) to convey to
parents the critical importance of vaccines; and 3) to be prevented from having to practice
substandard pediatric care.50 The AAP supports pediatricians having the option of terminating
the physician-patient relationship but points out they cannot do so without giving sufficient
advance notice to the family so care may be secured from a different provider. AAP also
recommends that pediatricians make such decisions only rarely and do so only after attempts to
work with the family.50
(2) Health risks. The risks of vaccine-preventable disease are far higher than the risks of
vaccination. Vaccines are subject to pre-licensure clinical trials and post-licensure monitoring of
adverse events to maximize their safety and efficacy.51-52
Although vaccines are considered very safe, adverse events related to vaccines do occur.
Adverse events following vaccination are generally categorized by frequency (common, rare),
extent (local, systemic), severity (hospitalization, disability, or death), causality, and
preventability (intrinsic to vaccine, faulty production, faulty administration).51 These events may
be coincidental with vaccination or vaccination may be causally related. Examples of local
adverse reactions, which may occur with up to 80% of vaccine doses, are pain, swelling, and
redness at the site of injection. These reactions are typically mild and self-limited. Systemic
adverse reactions include fever, malaise, headache, and rash. They commonly occur after
vaccination with live attenuated vaccines which need viral replication to produce an immune
response. Such reactions are usually experienced as symptoms of a mild form of the natural
disease. Severe, life-threatening adverse events, such as an acute allergic reaction (anaphylaxis)
to a vaccine, are very rare. Estimates are they occur with 1 in one million doses and can be
minimized by screening.51
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People harmed by vaccines are entitled to compensation. Claims may be filed and will be
adjudicated under the current system of no-fault compensation for vaccine injury established by
the Vaccine Compensation Injury Act of 1986.53
Better education about vaccine safety is needed for parents so they may more accurately
assess the benefits and risks of vaccination. Parents choosing to delay or avoid vaccinations, a
behavior now referred to as “vaccine hesitancy,” has become common.54-55 Recent national
surveys indicated that 50% of parents have concerns about vaccines and 89% of physicians
reported at least one vaccine refusal by a parent each month.54 Multiple reasons contribute to this
trend. Because vaccines have succeeded at reducing diseases to rare occurrences, parents are
more focused on vaccine risks than benefits. Tolerance of risks related to vaccines, which are a
preventive intervention for healthy children, is less than that for treatments used for children with
disease.51 Unfounded claims linking vaccines to autism received world-wide attention and
undermined confidence in vaccines and trust in government and health care providers. False or
misleading claims about vaccine risks are regularly touted by celebrities and widely available on
the Internet and social media.27, 54-57 Public health and the medical community are now
challenged with restoring confidence in vaccines. More research into the social, psychological,
and cultural factors affecting vaccine acceptance is needed, along with education tailored to the
concerns of diverse groups of parents.58
(3) Costs. Financial burdens of childhood vaccination for families have been reduced by the
Vaccines for Children (VFC) Program.59 Under VFC, the federal government purchases vaccines
and collaborates with state and local health departments to distribute them to public and private
health care providers at no cost. The vaccines may be administered to children 0-18 years who
are covered by Medicaid or are uninsured, underinsured, or American Indian/Alaska Native.
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{Note that VFC vaccines may be administered to underinsured children only in Federally
Qualified Health Centers (FQHCs) or at providers delegated by FQHCs. Some jurisdictions, such
as NYC, purchase vaccines for underinsured children with other federal funding to distribute to
all providers participating in VFC so that underinsured children may be vaccinated in their
medical homes.} Vaccines purchased with state funds are also distributed through VFC to
providers to vaccinate children covered by State Child Health Insurance Programs.59 Financial
barriers to vaccination for NYC children were further reduced by enactment of a New York State
law requiring health insurance policies written in New York State to cover all vaccines
recommended by the Advisory Council on Immunization Practices for children 0-18 years of
age.60
Further improvements in access to vaccines are needed to help reduce the considerable effort
required of parents to have their children vaccinated. For example, expanding school-located
vaccination programs and school-based health centers may remove the need for parents to take
off from work to bring school-aged children to a health care provider. Allowing children to be
vaccinated at pharmacies would also ease the burden on parents since pharmacies may be
conveniently located and open on nights and weekends. Expanding access should be
accompanied by support of integrated public health immunization information systems, such as
the NYC DOHMH Citywide Immunization Registry. These systems create a longitudinal record
of an individual’s vaccination history by collecting reports of vaccines administered by different
providers over time. They offer primary care providers, schools, parents, and individuals access
to vaccination histories so individuals may obtain needed vaccines and avoid overimmunizaton.61
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5. Are childhood vaccine mandates implemented fairly? Vaccine requirements may be
considered fair in that they apply to all children attending childcare, prekindergarten, and school
in a particular jurisdiction. Enforcement may be inconsistent across overburdened health
departments, childcare programs, prekindergarten programs, and schools, however.62 These
entities should strive to implement enforcement fairly and consistently, although this may
necessitate the investment of more resources which may not be available.
In the case of the NYC childcare influenza vaccine mandate, the parents who brought the
lawsuit against the mandate argued that the mandate was unfair because it applied only to
children in NYC and not to all children in New York State. While this position may seem valid,
it ignores the fact that NYC is a different environment than most of the rest of New York State.
NYC is more densely populated, and many NYC residents may come into contact with other
people frequently and closely by using public transportation to travel around the city. NYC
residents, therefore, may be more susceptible to diseases such as influenza which are spread by
casual contact. In other parts of the state, people may more easily travel in their own cars,
separate from other people. Consequently, residents of New York State outside of NYC,
particularly those living in suburban and rural areas, may be less vulnerable to disease
transmission. In January, 2017, the Centers for Disease Control and Prevention reported that
influenza cases were rising dramatically in US coastal cities, and that NYC, in particular, was
seeing steep increases in influenza activity.63
6. How can benefits and burdens of childhood vaccine mandates be fairly balanced? Public
health leaders and bioethicists call for balance and restraint in enacting vaccine mandates. They
propose that the highest priority should be for vaccines protecting against serious diseases
transmitted through casual contact.16, 41 This approach favors mandating influenza vaccine, for
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example, but would not support a mandate for human papillomavirus vaccine (HPV) which
protects against a sexually transmitted disease.
Childhood vaccine mandates are enacted by democratically elected state lawmakers or
appointed municipal authorities such as state health officials or the NYC Board of Health.
Community involvement in the decision-making of these bodies can take place through public
hearings and written comment periods. Parents and other concerned individuals from the public
should be encouraged to participate. Based upon personal observations while attending NYC
Board of Health meetings, public participation appears to be very low. Public notices of hearings
and comment periods are posted on the NYC DOHMH Web site, but interested members of the
public may not be aware of them. To encourage more public participation, notices should be
published more widely in media with a large readership such as local newspapers and the free
press.
Conclusion. The above analysis supports the conclusion that childhood vaccine mandates for
school entry, which effectively protect communities against serious diseases,16-17, 62, 64 are ethical
when enacted through a democratic process, are fairly enforced, and allow for legitimate
exemptions. Vaccine mandates for childcare may be less justifiable, however, because some
studies cast doubt on their impact on raising vaccination rates.20-21 More research is needed to
determine whether the benefits of vaccine mandates for childcare outweigh the burdens.
Alternatives to Vaccine Mandates: Theory-Informed and Evidence-Based Interventions
Vaccine mandates should be used sparingly to avoid anti-vaccination outcry and action.42 As
seen when Texas governor Rick Perry issued an executive order in 2007 for HPV vaccine for
girls entering middle school, mandates can touch off a major backlash that distracts from the
important benefits of vaccines.65-66 Alternatives to mandates are needed to increase vaccine
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acceptance and avoid backlash. Health behavior theory and evidence-based recommendations
may be powerful tools for understanding vaccination behavior and crafting interventions to
increase vaccination rates.67-70 Evidence-based recommendations for increasing vaccination
rates, issued by the Task Force on Community Preventive Services, offer guidance on
interventions found to be effective based on systematic reviews of the literature.71-72
Health Behavior Theories. Several theories of health behavior have been used to inform
studies of vaccination behavior and to develop interventions aimed at promoting vaccination.
These include the Health Belief Model, the Theory of Planned Behavior, and the Theory of
Reasoned Action,73-92 which are among the theories most widely used in public health.67-69, 92-93
They focus on individuals and are concerned with the relationship between perceptions or
intentions and health behaviors.67-68, 92-93 Some argue that these theories have very similar
constructs and differ primarily in their use of terminology.92 Support for each of these theories
may be found in literature reviews and meta-analyses; no one theory has been shown to be best
at explaining health behavior.67, 92 In the following paragraphs, the Health Belief Model,
Ecological Models, Social Marketing, and Nudge Theory are briefly described along with
examples of their application to vaccination.
Health Belief Model. The Health Belief Model (HBM) has emerged as possibly best suited to
understanding why people use (or don’t use) preventive services such as vaccination.92 Studies
have repeatedly demonstrated the ability of HBM constructs to predict vaccination behavior
among both adults and parents on behalf of their children and adolescents.73-87
The HBM was developed in the 1950s as a conceptual framework to explain individuals’
failure to participate in preventive services offered by public health departments.67-68, 76, 83 One of
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its first applications was to understand barriers to polio vaccination.92 According to the HBM,
individuals will (or will not) take recommended action to avoid a disease based on whether they
perceive themselves (or their children) to be personally at risk for it, that the disease may be
severe, and that the expected benefits of taking the action outweigh the costs or other barriers to
performing the action.79-80 The HBM’s core constructs are perceived susceptibility, perceived
severity, perceived benefits, perceived barriers, cues to action, and self-efficacy. The last
construct was added after the model was initially developed.67-68
A recent example of the use of the HBM was a study of over 11,000 parents of children aged
24-35 months using data from the Centers for Disease Control and Prevention (CDC) National
Immunization Survey.80 This study found that HBM constructs successfully predicted vaccine
acceptance. Parents who refused or delayed vaccines for their child were less likely to believe
their child was susceptible to vaccine-preventable diseases or that the diseases were severe
enough to warrant vaccination. These parents were also less likely to believe in the benefits of
vaccines, i.e., that vaccines are effective at preventing diseases, or that vaccines are safe.80
Vaccine safety concerns, fueled by unfounded claims of a link between vaccines and autism,
have become a barrier to childhood vaccination.94-96
Although clearly useful, the HBM has several limitations. The model’s predictive value has
been proven, but the effectiveness of HBM-informed interventions is not well understood and
needs further study.67 The HBM does not provide guidance on how to change people’s
perceptions to increase acceptance of preventive services such as vaccination.73 Constructs of the
model can be difficult to measure in cross-sectional studies when temporality cannot be
determined.67, 75 For example, an inverse relationship between perceived susceptibility and
vaccine acceptance may be due to vaccinated individuals perceiving themselves to be at low risk
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for disease because they are already vaccinated.67 Most importantly, as a model focusing on
individuals, the HBM does not address the physical and social environments in which health
behaviors are performed. Interventions aimed at changing individual behavior, without also
reducing economic, physical, or social barriers, are less likely to succeed.67, 93, 97-98
Ecological Models. Limited impact of individual behavior interventions has shifted the focus
of researchers and practitioners to ecological models.97,99-100 Ecological theory is based on the
premise that health results from a dynamic interplay between the demographic characteristics of
individuals, with socioeconomic status being among the most important, and the individual’s
social and physical environment comprising his or her ecosystem.100 Ecological models call for
intervening at multiple levels beyond the individual to the group, organization, community, and
policy.93, 99-100 A recent study of influenza vaccination during the 2009 H1N1 influenza
pandemic found that factors at the intrapersonal, interpersonal, institutional, and community
levels each predicted vaccine acceptance, offering support for targeting multiple levels as a more
effective approach than intervening at only one level.87
Limitations of ecological models are that they tend to be complicated and expensive. Further,
researchers may find it difficult to tease out which aspects of the model produce the desired
results.99
Social Marketing. The use of social marketing media campaigns, a community level
intervention, is being promoted by CDC to increase vaccination rates.72, 101 Immunization
programs in several US states and other localities are using social marketing to promote
influenza and human papillomavirus (HPV) vaccines, in particular.101-102 Increasing uptake of
HPV vaccine is a current CDC priority since series completion among adolescents remains
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suboptimal. NYC’s rate measured as of March 31, 2017 for the 3 recommended doses of HPV
for 13-17 year-old females was 58.7%, 103 below the Healthy People 2020 goal of 80%.104 (Note
that the Healthy People 2020 goal of 80% is for females aged 13-15 years for 3 doses of HPV
vaccine 104). The Advisory Committee on Immunization Practices recently approved a 2-dose
schedule for adolescents receiving the first dose before age 15 years, and with an interval of 5
months or longer between the first and second dose.105 Completion rates are expected to improve
with the new schedule.
Social marketing applies commercial marketing concepts to persuade individuals to perform a
recommended action for the benefit of the individual as well as the broader community or
society.101-102 Social marketing campaigns seek to increase social acceptability of a
recommended behavior.68 A key component of these campaigns is to target audiences which
have been segmented based on demographic characteristics, culture, environments and other
factors. Social marketing campaigns are based on the four “Ps”: Product, Price, Place, and
Promotion.100-101, 106 Nowak and colleagues applied the four “Ps” to vaccination: (1) product is
the behavior of accepting vaccination; (2) price is the financial cost of vaccine, the investment in
time and effort to get vaccinated, perceptions of vaccine safety and efficacy, and the social value
of adhering to a perceived community norm or the social costs of noncompliance; (3) place is the
setting for vaccine delivery, such as a physician’s office, school, or retail pharmacy, which may
or may not offer convenient access to vaccines; and (4) promotion is the relaying of messages to
encourage vaccination, often emphasizing personal stories that resonate with people’s
emotions.101
Storey and colleagues (2008) point out that health behavior theories are commonly used to
guide the planning and evaluation of social marketing interventions. As examples, they cite the
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following theories: (1) Integrated Model of Behavioral Prediction, which is mainly concerned
with cognitive or rational processes related to decision-making; (2) the extended parallel
processing model, which focuses on the effect of emotion on behavior and is often referred to as
fear management theory; (3) social learning theory, which posits that people learn behaviors by
observing others; and (4) diffusion of innovations, which focuses on dissemination of
information within a social environment and its impact on adoption of new behaviors.106 The
HBM and Theory of Planned Behavior may also be used to inform social marketing programs.102
Lessons learned from the application of social marketing to changing behaviors such as
tobacco use suggest that social marketing may be a promising strategy to increase vaccine
acceptance.101 A limitation of social marketing may be the financial resources typically needed to
support large-scale campaigns. Such an investment may be beyond the means of many
immunization programs.101
Nudge. The Nudge Theory, developed by behavioral economists Thaler and Sunstein (2008),
may also be applied to the challenge of increasing vaccine acceptance.107 This theory, grounded
in behavioral science research, posits that people can be influenced or “nudged “to make the best
decisions about their health and welfare by “choice architecture.” Governments may use choice
architecture to steer people toward adopting healthy behaviors by making small changes in
interventions to reduce barriers or leverage people’s desires to conform to social norms or follow
the path of least resistance. An example pertaining to vaccination involved a lecture given to
Yale University seniors about the risks of tetanus and the benefits of vaccination against
tetanus.107 Following the lecture, most students reported they were persuaded of the importance
of vaccination and planned to go to the student health center to get the vaccine. Only 3% actually
did so, however. A different group of seniors was given the same lecture, but these students were
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also given a campus map with the location of the health center circled and were asked to look
over their weekly schedules to plan a time get the vaccine. Of this group, 28% got vaccinated.
Both groups were likely to have known where the health center was, since they were seniors, but
small changes to allow them to see the health center on the map and think about the quickest and
easiest way to get there, and to plan when to fit the vaccination into their schedules, were
associated with a nine-fold increase in students getting vaccinated.107
Public health would benefit from wider application of theories such as the HBM, social
marketing, and Nudge. However, public health practitioners often lack exposure to theory, are
preoccupied with practical concerns, 67, 92-93 and may not have the time or resources to test and
apply theory. More work is needed to make theory accessible to practitioners and encourage its
use.92-93
Evidence-Based Recommendations to Increase Vaccination Rates
An additional source of guidance for improving vaccination rates in the absence of mandates
is the list of evidence-based recommendations issued by the US Task Force on Community
Preventive Services. These recommendations are based on results of a systematic review of the
literature on population-based interventions aimed at improving vaccination rates. Studies
reviewed include those which were, and were not, informed by health behavior theories.
Recommendations focus on three major categories of interventions: (1) increasing community
demand for vaccinations; (2) enhancing access to vaccinations; and 3) provider-based
interventions.71-72, 108-109 Since these recommendations together target multiple levels, including
the individual, group, organization, community, and policy, they may be thought of as an
ecological model for increasing vaccination rates.
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An example of a recommended intervention to increase demand would be community-wide
education combined with sending patient or provider reminder notices as a cue to action for
vaccination. One example of enhancing access would be reducing administrative barriers in
clinics by offering walk-in vaccination and expanding clinic hours to evenings and weekends. An
example of a provider-based intervention would be a physician issuing standing orders to allow
nurses to vaccinate patients by protocol without the need for a physician to be present.71-72
The Task Force cautions that although evidence demonstrates the effectiveness of
recommended interventions, they may not fit every population or context. Practitioners are urged
to tailor interventions to local conditions and use multiple, complementary interventions.71-72 Use
of tailored interventions is strongly supported by other researchers 93, 108-109 along with involving
staff members and clients in the planning and implementation of interventions.69, 93, 108
Vaccine mandates remain one of the most widely used evidence-based interventions to
increase vaccination rates and prevent disease. In the following sections, the rationale for NYC’s
childcare influenza vaccine mandate is examined as well as the mandate's impact on vaccination
rates among NYC children 6-59 months of age.
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Section 3: Methodology
Study Design: Convergent Mixed-Methods
The two aims of this dissertation guided a mixed methods explanatory study of the rationale,
impact, and ethics of the NYC childcare influenza vaccine mandate. The study followed a
convergent mixed methods research design in which qualitative and quantitative methods were
used complementarily.110 Findings from each method were analyzed independently and then
integrated in the discussion and conclusion sections of the dissertation. A mixed methods
approach was ideally suited to examining the mandate’s context, i.e., why the mandate was
enacted, as well as the mandate’s content, 110 i.e., the impact of the mandate on influenza
vaccination coverage rates among NYC 6-59-month-olds.
Aim 1: Single-Case Study with Record Review. Qualitative methods, specifically a singlecase study with record review, 111 were used to achieve Aim 1. The single-case design was
selected because the NYC mandate is unusual in that it was enacted and implemented by a city
instead of a state and NYC is the only such jurisdiction to do so to date.
Aim 2: Short Interrupted Time-Series. Quantitative methods, specifically a short
interrupted time-series, were used to achieve Aim 2. The interrupted time-series is considered
one of the strongest quasi-experimental research designs.112 In this design, data are collected and
analyzed at regularly spaced intervals over time before and after the introduction of an
intervention to determine whether the intervention produced effects greater than underlying
secular trends. The interrupted time-series may be considered an effective alternative to an
experimental design when random assignment of the study population to an intervention versus a
control condition is not feasible.112 A special type of time-series, the interrupted time-series is
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used to assess the effects of an intervention occurring at a specific point in time on a dependent
variable of interest. Interrupted time-series studies have been widely used to examine the impact
of policy changes on the health behaviors and outcomes of targeted populations.112-127 Hence,
this design was appropriately suited to an investigation of the effect of the NYC childcare
influenza vaccine mandate on influenza vaccination rates among NYC 6-59 month olds.
A limitation of interrupted time series studies is that a minimum of 8 time points before and 8
points after the intervention are needed to assess changes statistically.128 In general, 12 time
points before and 12 points after the intervention are recommended for a statistical analysis using
segmented regression.129 More data points over a longer period of time better inform an
assessment of secular trends before an intervention and the duration of effects following an
intervention.112
This study was a short time series because it included fewer data points: 8 before the mandate,
2 during the mandate, and 1 after the mandate’s suspension. Although less rigorous than a longer
time series, the short time series may still support causal inference.112 The use of 8 preintervention data points reduced threats to internal validity compared to a design relying on only
1 or 2 pre-intervention data points. This study was also strengthened by the use of a control
group: children 5-8 years of age who are recommended to receive annual influenza vaccination
but were not directly affected by the childcare mandate. A limitation was that the number of data
points in the time series was not sufficient for a statistical analysis using segmented regression.
The chi-square test was used to assess the statistical significance of differences in vaccination
rates in age groups before and during the mandate. Limitations were encountered in the use of
the chi-square test. (See Limitations section).
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There were several reasons for the short time series. First, the NYC DOHMH’s goal for the
mandate was to raise influenza vaccination rates among children 6-59 months of age in each
annual influenza season (July 1 - June 30). Vaccination rates are measured by the NYC DOHMH
two times each season: at the mid-point on December 31, and at the end of the season on June
30. These measurement intervals allowed for a maximum of 2 data points per annual season. The
vaccination rate as of December 31 in each season was chosen as the outcome or dependent
variable because: 1) the mandate required a child to receive vaccine by December 31 of each
season; and 2) the mandate was suspended on December 16, 2015, 8-9 close to December 31 of
the second season following enactment of the mandate.
The first data point for the pre-mandate period was December 31 in the 2006-07 season.
Influenza vaccine was recommended for all 6-59-month-olds starting with that season. (Influenza
vaccine was recommended for 6-23-month-olds in the 2004-05 season, 130 but the
recommendation for the full age range of 6-59-month-olds began in 2006-07. 131) In 2008-09, the
recommendation was expanded further to include all children 6 months through 18 years of
age.132 The season immediately before the NYC childcare influenza vaccine mandate took effect
was 2013-14, allowing for a pre-mandate examination of the influenza vaccination rate as of
December 31 from 2006-07 to 2013-14, a total of 8 annual seasons. The mandate was enacted in
January, 2014, and began July 1 of the 2014-15 season. It was then suspended near the mid-point
of its second season (2015-16), on December 16, 2015.8-9 Thus, vaccination rates as of December
31 in two seasons while the mandate was in effect were available for examination. One data
point, December 31, 2016, allowed for examination of vaccination rates at the mid-point of one
season after the mandate was suspended.
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Data Sources
Aim 1: Records. The data sources included in the review of records for the single-case study
included a NYC DOHMH briefing, presentations by NYC DOHMH and the states of
Connecticut and New Jersey, NYC Board of Health documents, public comments to the NYC
Board of Health, information on the Web sites of NYC DOHMH and other states, a published
study of the impact of Connecticut’s childcare influenza vaccine mandate, and other literature
reviewed by NYC DOHMH on influenza disease burden, the safety and effectiveness of
influenza vaccines, and other topics. Court case arguments and rulings were also examined.
These sources were reviewed over the timeframe leading up to the NYC mandate’s enactment,
from approximately 2012 through January 2014, as well as afterwards, from February 2014 to
date. Literature on influenza disease burden and influenza vaccine safety and effectiveness
primarily included papers published from the year 2000 and later. The results of the quantitative
study conducted for Aim 2 was also a data source for the single-case study.
Aim 2: The NYC Citywide Immunization Registry. The data source for the quantitative
study conducted for Aim 2 was the Citywide Immunization Registry, which is the NYC
DOHMH’s immunization information system (IIS). The main purposes of an IIS are to collect
and consolidate reports of vaccinations administered to individuals by all health care providers in
a jurisdiction and share these records with other health care providers, health plans, schools,
parents, and individuals to promote increased vaccination coverage rates. Operated by public
health departments in 49 of 50 states, 5 cities, and the District of Columbia, IISs are supported by
funding from the Centers for Disease Control and Prevention (CDC), states, and local
governments.133
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The Citywide Immunization Registry started citywide in 1997 after the NYC Board of Health
amended the NYC Health Code to require health care providers to report all vaccinations
administered to children in NYC to the DOHMH.134 (A law was enacted by New York State in
2006 requiring reporting of childhood immunizations statewide.135) The Citywide Immunization
Registry currently receives reporting of an estimated 90% of vaccinations administered to NYC
children 0 - 18 years of age.103 All children born in NYC are enrolled in the Citywide
Immunization Registry via a file upload of birth certificate data from the DOHMH Office of
Vital Records twice weekly. Children born outside of NYC but living in NYC are enrolled in the
Citywide Immunization Registry when they are vaccinated in NYC and a provider reports the
vaccination. The Office of Vital Records also provides the Citywide Immunization Registry with
updates on deaths and adoptions.103
Currently, most vaccinations are reported by health care providers who document
vaccinations in their electronic health record (EHR) system which automatically sends the
information in real-time to the Citywide Immunization Registry based on national Health Level 7
(HL7) messaging standards.136-137 The Citywide Immunization Registry database includes a
range of patient and provider demographic variables and detailed vaccination data. Citywide
Immunization Registry data have been used in many published studies to examine vaccine
uptake and effectiveness, provider immunization practices, methods to improve vaccine safety,
and interventions to increase accountability for publicly purchased vaccines distributed to health
care providers through the federal Vaccines for Children program.138-141 The Citywide
Immunization Registry, as an administrative data source, had limitations for this study. (See
Limitations section.)
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Variable Definitions
Aim 1: Themes and Framework Concepts. The variables in Aim 1 were the themes
identified from record review using a grounded theory approach, 142 as well as the concepts
included in the Kass23 and Field and Caplan24 frameworks. For the Kass framework, these
included the six questions related to the goals of a public health intervention as they applied to
the NYC childcare influenza vaccine mandate. Specifically, the six questions informed an
examination of the mandate’s effectiveness in achieving its goals, benefits and burdens, potential
alternatives, and capacity to be implemented fairly.23 Application of the Field and Caplan
framework focused on the competing ethical values of parental autonomy and the NYC
DOHMH obligation for beneficence, utilitarianism, justice, and nonmaleficence.24
Aim 2: Dependent Variable: Influenza Vaccination Rates over Time. The dependent
variable for Aim 2 was influenza vaccination rates among children 6-59 months and 5-8 years of
age as of December 31 in each annual influenza season from 2006-7 through 2016-17. This
variable was calculated by the number of children in the age group who had one or more doses of
seasonal influenza vaccine administered during July 1 through December 31 in each annual
influenza season documented in the Citywide Immunization Registry (numerator) divided by the
US Census Bureau Vintage 2016 population estimate for the age group (denominator).143 (Note
that the US Census Bureau vintage population estimates take into account annual population
change based on data for births, deaths, and domestic and international migration. These data are
used to update the estimates from the most recent decennial census. The vintage estimates have
been shown to be very accurate. The average absolute difference between the final total resident
population estimates from 2000 to 2010 and the 2010 Census counts was approximately 3.1
percent for all counties.144)
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Some children, based on age and history of influenza vaccination, are recommended to
receive two doses of influenza vaccine in a season for full protection against the disease.132 The
NYC childcare mandate required only one dose, however. Monovalent H1N1 influenza vaccine
doses administered to children during the H1N1 pandemic in 2009-10 were excluded.
Aim 2: Independent (Exposure) Variable: The NYC Childcare Influenza Vaccine
Mandate. Influenza vaccination rates as of December 31 in each annual influenza season before
the mandate, from 2006-7 through 2013-14, while the mandate was in effect, from 2014-15
through 2015-16, and after the mandate was suspended, 2016-17, were examined. The mandate
required children 6-59 months of age attending NYC-regulated childcare programs and public
school prekindergarten to receive 1 dose of influenza vaccine during the period of July 1 through
December 31 of each annual influenza season. In the first season of the mandate (2014-15),
education was the only mode of enforcement for childcare programs and public school
prekindergarten. In the second season (2015-16), starting January 1, 2016, operators of childcare
programs were subject to fines for failing to exclude children without a documented dose of
influenza vaccine.1, 8-10 Public school prekindergarten programs were not subject to fines, and the
NYC Department of Education (DOE) decided against requiring principals to exclude
unvaccinated children. DOE staff did inform parents of public school prekindergarten students
that influenza vaccine was required. Fines against childcare program operators and exclusion of
children attending childcare programs never took place, however, because the mandate was
suspended December 16, 2015, approximately 2 weeks before these enforcement measures
would have begun.8-9 The impending threat of these measures was in effect from July 1, 2015,
through December 16, 2015, however.
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Aim 2: Study Population. Children included in the Aim 2 study were 6-59 months or 5-8
years of age for each entire annual influenza season. Children who would have aged in or out of
the age groups during the season were excluded. This method of selecting the population for
studies of influenza vaccination rates by age group, called the period of time assessment – not
allowing aging in or out method, is used by researchers at the Centers for Disease Control and
Prevention and recommended by the American Immunization Registry Association.145-146 Using
this method, all children included have the same opportunity to be vaccinated during the annual
influenza season.145-146 In addition, the children 6-59 months of age in this study were subjected
to the mandate for the entire time it was in effect. The age groups are defined by a date of birth
range in this method.145-146 For example, in this study, children aged 6-59 months during the
2016-17 annual influenza season were born during 7/1/2012 to 1/1/2016.
Excluded from the study population were: 1) children living outside NYC, defined as those
children whose most recent address in the Citywide Immunization Registry included a zip code
outside of NYC; 2) children for whom a provider indicated that they had moved out of NYC; and
3) children known to be deceased based on a vital record indicator or report from a provider.
The 6-59-month-olds were the intervention group because they were specifically covered by
the mandate. A limitation of this study was that it was not possible to identify which individual
6-59 month-old children were attending childcare and prekindergarten. (See Limitations section.)
The 5-8-year-olds were selected as a non-equivalent control group because the Advisory
Committee on Immunization Practices also recommends that they receive annual influenza
vaccination132 but they were not directly affected by the mandate. Since the children in both age
groups lived in NYC, they would have been affected similarly by history, maturation, and other
contextual factors apart from the mandate which may have influenced vaccination rates.
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Data Analysis
Aim 1: Use of Grounded Theory and Application of Conceptual Frameworks
Data gleaned from record review was analyzed using a grounded theory approach.142
Concepts and themes were identified and coded for analysis using a manual system. The findings
from record review were integrated with those of the Aim 2 quantitative analysis in the
discussion and conclusion sections of this dissertation. The Kass23 and Field and Caplan24
frameworks were applied for an ethical analysis of the mandate. The second question in the
application of the Kass framework, pertaining to how effective the mandate was in achieving its
public health goal, was informed by the findings from the Aim 2 quantitative study.
Aim 2: Vaccination Rate Trends
Influenza vaccination rates as of December 31 each season among the intervention group of
6-59-month-olds were examined and compared to those of the control group of 5-8-year-olds
from the 2006-7 influenza season through the 2016-17 season. Rates were calculated based on
the number of children with > 1 influenza vaccination documented in the Citywide Immunization
Registry as of April 20, 2017 for all children in the age groups in all influenza seasons divided
by the Census Vintage 2016 population estimates for the age group in the corresponding year.
The date of April 20, 2017 was selected to allow ample time for vaccinations administered
during July 1 - December 31, 2016 to be reported to the Citywide Immunization Registry.
Reporting to the Citywide Immunization Registry is timely. A recent analysis found that of all
vaccinations administered to children 0-18 years of age in 2016 and reported to the Citywide
Immunization Registry, 96% were reported within < 30 days of date of administration.147

36

A stratified analysis of influenza vaccination rates by one-year age groups was conducted
among the aggregate groups of 6-59-month-olds and 5-8-year-olds. Children were assigned to a
one-year age group based on age as of December 31 each season. Children in the stratified 6-59month-old group were 1, 2, 3, and 4-4.5 years. The 5-8-year-olds were 5.5 to <6 years, 6, 7, and
8-8.5 years. As mentioned earlier, the chi-square test was conducted to assess the statistical
significance of differences in vaccination rates between different (independent) age groups
before and during the mandate. Limitations were encountered with the test. (See Limitations
section.)
The purpose of all analyses was to determine whether the mandate was associated with an
increase in influenza vaccination rates among 6-59-month-olds, and the subgroups of 1, 2, 3 and
4-year-olds, above the secular tend in response to the mandate and whether vaccination rates
may have declined due to the mandate’s suspension. SAS version 9.4 (SAS Institute, Inc.) and
Microsoft Excel 2013 (Microsoft Corp.) were used for analyses.
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Section 4: Results
Aim 1 Findings: Themes Identified
Experience in Connecticut and New Jersey. NYC DOHMH’s interest in pursuing a
mandate for influenza vaccination of children attending childcare began in June 2012 when the
Health Commissioner was briefed by a colleague from Connecticut on data following that state’s
mandate.148 In 2010, Connecticut became the second state in the US (after New Jersey) to
implement a childcare influenza vaccine mandate and was seeing evidence of a rise in
vaccination rates and a reduction in influenza-associated hospitalization rates among children < 4
years post-mandate. Connecticut is one of the CDC’s 11 Emerging Infections Program (EIP)
surveillance sites and evaluates influenza-associated hospitalization rates annually.2
The Connecticut mandate required all children 6-59 months of age attending licensed
childcare and preschool to receive at least 1 dose of influenza vaccine by January 1 each year.
(Connecticut originally required children 6-59 months of age who had not received influenza
vaccine in a previous season to receive 2 doses, as recommended by the Advisory Council on
Immunization Practices.13 Connecticut later determined it was not feasible to enforce a 2-dose
requirement, however, because it was too difficult for childcare personnel to identify which
children needed 2 doses.149-150)
The impact of Connecticut’s mandate on influenza vaccination rates was seen in a comparison
of data from the National 2009 H1N1 Flu Survey for 2009-10 and the National Immunization
Survey-Influenza (NIS-Flu) for 2011-12. Among all Connecticut children 6-59 months of age,
rates increased from 67.8% (95% confidence interval [CI] = 61.1% - 74.5%) in 2009-10, 2 the
season before the mandate, to 83.9% (CI = 77.5% - 90.3%) in 2010-11, the first season of the
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mandate. EIP data was showing a sharp decline in the influenza-associated hospitalization rate
among 0-4-year-olds in the 2010-11 and 2011-12 seasons.148 (Connecticut later published an
analysis of EIP data showing the rate of influenza-associated hospitalizations among Connecticut
children < 4 years declined 12% when comparing 2007-08 to 2012-13, two severe seasons with
the same predominant circulating strain of influenza virus. This was the largest percentage
decrease among all 11 EIP sites.2)
The Connecticut data prompted the NYC Health Commissioner to direct the DOHMH Bureau
of Immunization to research the possibility of a childcare influenza vaccine mandate in NYC. An
early step was to invite an epidemiologist from the Connecticut Department of Public Health to
speak at the Bureau of Immunization’s quarterly childhood coalition meeting in December 2012.
The childhood coalition includes pediatricians and other immunization providers from the
community, health plan representatives, DOHMH staff, and other immunization stakeholders.
In addition to presenting Connecticut’s data on vaccination and hospitalization rates, the
speaker described Connecticut’s legal process for enacting the mandate.149 Connecticut’s
Department of Public Health (DPH) added influenza vaccine to the list of vaccines required for
childcare settings without a regulatory change. This was possible because immunization
requirements for childcare are tied by state law to the standard of care, which is determined by
the national Advisory Committee on Immunization Practices. This Committee recommended
annual influenza vaccination for 6-23-month-olds in 2004 and expanded the recommendation to
include 24-59-month-olds in 2006.130-131 The Connecticut DPH is authorized to decide when to
enforce a newly recommended vaccine. The decision is based on vaccine supply, established
uptake (> 50% vaccination rate), provider acceptance, and vaccine safety.151
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The Connecticut DPH needed to make a regulatory change to add the requirement for 24-59month-olds attending school-based programs accredited by the state Department of Education.
School immunization requirements are in state laws, thus requiring a regulatory change. Little
opposition was voiced at public hearings. The DPH speculated this was likely because the
hearings occurred soon after the 2009-10 H1N1 influenza pandemic and the public’s perception
of influenza as a potentially serious disease was still fresh. 151 Changing the regulation took an
additional year, delaying the mandate’s start for school-based preschool to 2011-12.2,150-151
The Connecticut DPH communicated the influenza vaccine requirement by sending notices to
childcare and healthcare providers seven months in advance of the January 1 deadline. The DPH
also held workshops with several large childcare programs the summer before the mandate
started. The state Department of Education sent notices to the schools. Printed materials were
posted to the DPH Web site. Childcare providers and schools were asked to notify parents and
collect children’s immunization records throughout September through December. School
nurses, who were accustomed to checking immunization records once at the beginning of the
school year, expressed concerned about the burden of continuous monitoring.149-151
As of January 1 each season, childcare providers and schools in Connecticut were required to
exclude unvaccinated children. State childcare licensing employees, who were already
conducting routine inspections and checking compliance with other vaccine requirements, were
authorized to issue citations when children who had not received influenza vaccine were found in
attendance. Timely monitoring of the new requirement was a challenge for the DPH because
state immunization surveys completed by childcare programs and schools were due in the fall,
months after influenza seasons ended in June. Consequently, collection of influenza vaccine data

40

was separated from the other vaccines and the influenza survey was moved to January of the
current season.149-151
The Connecticut epidemiologist also described the public’s response to the mandate. The
DPH received an average of 10-15 telephone calls per day for 6-7 months after the mandate
started.150-151 Calls came from parents, childcare providers, and some physicians inquiring about
influenza vaccine safety, effectiveness, access, and compliance with the new requirement. In
retrospect, Connecticut staff realized it would have been helpful to send out posters to childcare
programs and provide other educational materials for parents. Of considerable concern was that
the DPH saw an increase in religious exemptions in response to the influenza vaccine
requirement. A later analysis showed that religious exemptions specifically for influenza vaccine
increased from 2.1% in 2010-11 to 3.8% in 2013-14.150
Despite the challenges, Coalition members found Connecticut’s presentation to be a
persuasive argument in favor of a mandate. Limitations of the data on vaccination rate increases
and the decline in hospitalization rates were discussed by the Connecticut epidemiologist and
coalition members, however. NIS-Flu data is based on unverified, parent self-report of child’s
vaccination status and has a small sample size. (Unlike NYC, Connecticut did not have
immunization registry data to support a local analysis of vaccination rates.) Comparisons of
influenza–associated hospitalization rates in different seasons must be interpreted with caution
because circulating influenza strains and vaccine formulations change each season. Disease
burden in different influenza seasons ranges from mild to severe, and the match between the
vaccine and circulating influenza virus strains is good in some years and poor in others.
Consequently, conclusions about the impact of vaccination rates on influenza-associated
hospitalizations are difficult to draw. A further limitation was that influenza vaccination trends in
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the pre-mandate period were not evaluated, leaving open the possibility that rate increases may
have been at least partially due to an underlying secular trend.
The NYC DOHMH Bureau of Immunization also reached out to the New Jersey Department
of Health. Through phone calls and materials sent, New Jersey shared that they first implemented
a childcare influenza vaccine mandate in 2008-09. The policy required children 6-59 months of
age attending licensed childcare or preschool to receive at least 1 dose of influenza vaccine
between September 1 and December 31 each year. Immunization requirements for childcare and
school were in state law, so enacting the mandate required a regulatory change and support of the
state legislature. The process took two years to complete, from 2006 to 2008.151-153
The proposal for New Jersey’s mandate was initially met with public pushback.151, 152 Antivaccine groups organized a protest in the state capitol which led to media coverage.152 Despite
evidence to the contrary, parent activists claimed that influenza was not a serious disease, that
the vaccine was not effective, and that the vaccine was harmful because it contained thimerosal,
a preservative containing mercury. These parents also complained that too many vaccines were
being mandated.151, 153
In response, the New Jersey State Vaccine Preventable Disease (VPD) Program held meetings
throughout the state with school nurses, parent organizations, and childcare staff. State VPD staff
developed educational materials for posting on Web sites and held conference calls and webinars
to educate nurses and other medical professionals. State VPD staff also conducted outreach to
professional organizations to build support, and worked collaboratively with the State
Department of Education on implementation strategies.152

42

Anti-vaccine activists eventually challenged the mandate in the New Jersey Supreme Court.
The mandate was upheld, but New Jersey state staff reported they lost public goodwill during the
heated debates.154 An additional setback was that the protest and debates led New Jersey state
legislators to weaken requirements for religious exemptions to vaccines.151-154 Religious
exemptions increased among children attending preschool programs from 0.4% before the
mandate (2007-08) to 2.0% after it (2011-12).155
New Jersey reported that estimating the vaccination rate among 6-59-month-olds before the
mandate was a challenge. The state did not collect influenza vaccination data from childcare
programs at that time and national surveys of influenza vaccination had not yet begun. However,
the New Jersey Collaborative for Excellence in Public Health conducted a study which estimated
the influenza vaccination rate among New Jersey children was 57% before the mandate.154
Despite experiencing poor compliance with the mandate in its first season (2008-09), and
needing to suspend the mandate in 2009-10 because of a seasonal influenza vaccine shortage
related to the H1N1 pandemic, 152, 154 New Jersey achieved success in increasing vaccination
rates quickly. In 2010-11, the influenza vaccination rate for New Jersey 6-59-month-olds reached
77.1% (CI = 70.3% - 83.9%), based on NIS-Flu data.156
Later results from NIS-Flu indicated that the post-mandate vaccination rate increases in New
Jersey and Connecticut continued. In 2012-13, the rate among 6-59-month-olds in New Jersey
rose to 88.0% (CI = 82.6 % - 93.4%), and Connecticut’s rate increased slightly to 84.1% (CI =
78.2% - 90.0%).2, 156 In alignment with the NIS-Flu estimates, Connecticut’s state survey of
childcare programs estimated that 87.1% of the 55,640 children aged 6-59 months enrolled in
licensed childcare in 2012-13 had received > 1 dose of influenza vaccine.2 In contrast to the New
Jersey and Connecticut rates, New York State’s influenza vaccination rate in 2012-13 for 6-5943

month-olds was far lower at 70.2% (CI = 65.4% - 75.0%), according to NIS-Flu.156 NYC
estimates were not available; NIS-Flu began producing estimates of influenza vaccination rates
for 6-59-month-olds in NYC in 2013-14. NYC’s rate for 6-59-month-olds in 2013-14, the year
before NYC’s mandate, was 73.6% (CI = 67.0% - 80.2%).156
What Would Success Look Like? Informed by the experience in New Jersey and
Connecticut, the NYC DOHMH Bureau of Immunization roughly estimated that a childcare
influenza vaccine mandate in NYC had the potential to raise influenza vaccination rates among
all NYC 6-59-month-olds by 4.6 percentage points. The Bureau calculated this estimate based
upon the assumption that the vaccination rate for the approximately 89,307 children 6-59 months
of age attending city-regulated private childcare and preschool in 2012-13 would rise in response
to the mandate from approximately 60% (53,584/89,307) to 84%, (75,018/89,307), resulting in
an additional 21,434 children receiving vaccine. This would produce an increase in the
proportion of all NYC 6-59- month-olds vaccinated against influenza annually from 60%
(279,000/465,000) to 64.6% (300,434/465,000). (Note that different methods and census
denominators were used for these vaccination rate estimates than those used in the Aim 2
analysis.)
The approximately 22,014 children in public school pre-kindergarten in NYC in 2012-13 4
were not included in the estimate because the NYC DOHMH was not able to enforce the
mandate in public schools in the same way as it could for childcare. In city-regulated childcare,
the NYC DOHMH Bureau of Child Care conducts inspections and issues violations against
operators for failing to exclude unvaccinated children. Violations could result in fines ranging
from $200 to $2,000.10 NYC DOHMH does not issue violations against public schools, and the
NYC Department of Education (DOE) decided against excluding noncompliant children. (Note
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that the NYC DOE would have been required to exclude noncompliant children had the
influenza vaccine requirement been included in state law in addition to the NYC Health Code.)
The Basic Rationale. The Bureau conducted an extensive literature search, and combined the
findings with information gathered from New Jersey and Connecticut, to prepare a briefing
document for the Commissioner.154 The document covered: a) disease contagiousness; b) health
and economic burden of disease; c) vaccine safety, effectiveness, and availability; d) vaccine
uptake; e) potential for producing herd immunity; f) methods for monitoring and enforcement;
g) compliance with other current immunization requirements; h) legal issues; and i) potential for
public backlash.
The NYC Health Commissioner and other DOHMH leaders used the briefing document to
inform deliberations for seeking the mandate. Over the course of nearly one year, from mid-year,
2012, to spring, 2013, the DOHMH leadership reached the decision to proceed. The
Commissioner presented the proposal for the mandate to the Mayor in March, 2013.157 The NYC
Mayor, Michael Bloomberg, was well known to be a strong supporter of public health. Shortly
thereafter, in September, 2013, the Assistant Commissioner of the Bureau of Immunization
presented the proposal to the NYC Board of Health.158 The following is a summary of
information considered by the DOHMH leadership in making their decision.
a) Contagious of disease. Influenza is a highly contagious disease transmitted by respiratory
droplets from coughing and sneezing.12 Childcare programs and schools are congregate settings
in which the spread of infectious diseases such as influenza occurs easily.14, 158-159 In these
settings, a large number of people are brought together increasing the chances of an infected
person coming into contact with an uninfected person.158 Children exhibit poor respiratory
hygiene, facilitating rapid spread of the virus. Keeping children home when they are sick does
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not prevent disease transmission because individuals are typically infectious before symptoms
begin.158, 160 Attack rates for influenza among children younger than 5 years of age have been
found to range from 35% to 45%.161 Moreover, children are a major source of influenza
transmission within communities. Compared to adults, children shed larger amounts of influenza
virus for longer periods of time.14, 158, 162
The risk of acquiring influenza often starts to increase in October, highlighting the need for
vaccination early in the annual influenza season. Reported cases of influenza usually peak
between December and February, although influenza activity may continue into May.163
b) Health and economic burden. Among the general population in the US, influenza is
associated with an average of over 200,000 hospitalizations each year.12 Influenza-associated
deaths range from 3,000 to 49,000 annually, depending on the types of influenza viruses
circulating during the season.12, 15 The majority of influenza-related deaths occur among people
age 65 years and older,12 but an average of 92 children <5 years die of influenza-associated
causes each year in the US.164 Pediatric deaths ranged from 35 to 282 annually over four seasons
from 2009-10 to 2013-14. Of the children who died, 40% had no recognized chronic health
condition and 90% had not received influenza vaccine.158 Children 0-4 years of age make up 6%
of the US population but account for 10-18% of influenza associated hospitalizations.158
Estimates are that one influenza case in a child younger than 5 years results in out-of-pocket
costs of $52- $178 and loss of parent wages ranging from $222 to $1,456. For every 100 children
with influenza, an estimated 195 parent work days are lost.158, 165
c) Vaccine safety, effectiveness, and availability. Vaccination has been shown to reduce the
risk of a medical visit for influenza by 56% among healthy children 6 months - 5 years of age.166
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Annual influenza vaccination is necessary because immunity following vaccination may be less
than one year due to waning vaccine-induced antibodies and because influenza viruses often
change each year. Influenza vaccine effectiveness varies each year depending on the match
between the virus strains in the vaccine produced and the circulating strains that year.12 In
children younger than 6 years, influenza vaccine efficacy has ranged from 59% to 82% while
vaccine effectiveness ranged from 25% to 36%.154, 167 Studies have shown that influenza
vaccines are effective in children older than 2 years but less beneficial in 6-24-month-olds.154, 167
Injectable and nasal spray influenza vaccines were available for use in children, and both had
good safety records. Before 2015, the nasal spray vaccine was found to be more effective at
preventing influenza in children.154 (In the 2015-16 and 2016-17 seasons, the Centers for Disease
Control and Prevention recommended against use of the nasal spray because studies indicated it
had been ineffective in recent seasons.160, 163) Influenza vaccines have been available in sufficient
supply, and early in the season, for the 6-59 month-old age group in recent years.
d) Vaccine uptake. Influenza vaccination rates among NYC 6-59-month-olds had increased
from approximately 47% in 2008-09, when it was routinely recommended for the full age group,
to about 60% in 2011-12, according to the NYC DOHMH Citywide Immunization Registry.103
The progress made signaled acceptance of the vaccine by many parents and health care
providers. More than one-third of children younger than 5 years remained unvaccinated,
however.103, 154
e) Potential for producing herd immunity. Several major studies have indicated that
vaccinating children produces herd immunity and interrupts community transmission of
influenza.154, 162, 168-171 One example was from Tecumseh, Michigan, in which 85% of schoolaged children were vaccinated against influenza before the 1968-69 influenza epidemic. The rate
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of influenza-associated illness was 67% lower in Tecumseh compared to a neighboring town
which had not vaccinated its children.168 Research using modeling techniques has suggested that
influenza vaccination coverage of just 20% among schoolchildren reduces overall mortality in
adults aged 64 years and older more effectively than a vaccination rate of 90% for older
adults.170 Children’s immune systems respond better to influenza vaccine than those of elderly
people, so vaccinating children may be the best approach to protecting those most vulnerable to
influenza-associated complications and death.170
A limitation of the research on herd immunity was that it was mostly conducted among
school-aged children.154 Few studies have examined the impact of vaccinating younger children
on preventing community transmission of influenza. One study found that vaccinating children
in childcare against influenza was associated with a 42% reduction in febrile respiratory illness
among unvaccinated household contacts, but the study was limited by a small sample size.159
f) Methods for monitoring and enforcement. The NYC DOHMH Bureau of Immunization
is responsible for enforcing vaccination requirements in schools. Compliance among children
attending pre-kindergarten programs in public schools is monitored through data provided by the
NYC Department of Education from their Automate the Schools (ATS) database. DOE sends
ATS data to the Bureau monthly, allowing for timely monitoring of compliance and prompt
outreach to schools with suboptimal compliance. The Bureau sends notices to schools with less
than 95% of children in grades kindergarten through 12 who meet vaccination requirements
throughout the school year. School principals are reminded that they may be subject to fines for
failing to enforce immunization requirements. The Bureau’s outreach has been very effective:
nearly 99% of public school children are in compliance with immunization requirements by the
end of a typical school year.172
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Monitoring and enforcement of vaccination requirements among non-public school programs
cannot be done in a timely manner. The Bureau monitors compliance among children attending
childcare and preschool in non-public school settings primarily with aggregate data reported on
an annual survey to the New York State Department of Health. The Bureau of Immunization also
conducts audits among a sample of non-public school programs to supplement the self-reported
state survey data. The audits do not cover all programs, and do not allow for identification of
individual, noncompliant children for exclusion. The NYC DOHMH Bureau of Child Care
conducts routine inspections of city-regulated, non-public school childcare and preschool
programs, however, and is authorized to issue violations for failing to exclude unvaccinated
children.
The NYC DOHMH Bureau of Immunization recognized that an influenza vaccine
requirement would be particularly difficult to monitor and enforce because, unlike other
vaccines, it is required every year.
g) Compliance with other current immunization requirements. In 2013, children
attending childcare and preschool were required to be vaccinated against diphtheria, pertussis,
tetanus, polio, measles, mumps, rubella, hepatitis B, Haemophilus influenzae type b,
pneumococcus, and varicella. By the end of the 2011-2012 school year, 99.1% of public school
children and 92 % of children attending non-public school childcare programs were in
compliance. Less than 1.0% of children were exempt from immunization requirements for
medical or religious reasons.4
h) Legal issues. Childcare and school immunization requirements are in New York State
law. Adding a vaccine to the list of required vaccines would normally require the state legislature
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to approve the change. NYC DOHMH officials had advocated for changing state law but the
proposal was not taken up by the New York State Department of Health and did not move
forward. The NYC Health Commissioner asked the NYC DOHMH General Counsel to
determine whether the NYC Board of Health had the authority to require influenza vaccine for
childcare and preschool by amending the NYC Health Code. There was a precedent: NYC
required 4 doses of diphtheria, tetanus and acellular pertussis (DTaP) vaccine for kindergarten
compared to 3 doses required by state law.
The General Counsel determined that the influenza vaccine could be mandated for childcare
and preschool by amending the NYC Health Code. Developing the legal strategy was a challenge
because not all childcare facilities in NYC were city-regulated, however. The General Counsel
decided to require influenza vaccine for children attending city-regulated childcare and
preschools but not New York State-regulated facilities or unregulated facilities.
Facilities included were those covered under NYC Health Code Articles 47 and 43.158 The
Article 47 facilities are childcare centers (non-residential) for 0-5-year-olds that have an average
of 45 children enrolled, and private and religious school-based programs for 0-2-year-olds with 3
or more enrollees. Combined, Article 47 facilities had a capacity of 124,000 children. Article 43
facilities are public school-based programs for children 3-5 years with approximately 32,000
children enrolled (2012-13 school year). Facilities not covered were state-regulated family
childcare, serving a maximum of 6 children aged 0-5 years, and group family childcare serving a
maximum of 12 children aged 0-5 years. Total capacity for family childcare is 20,000 and group
family childcare is 60,000. Unregulated childcare includes home-based providers serving less
than 3 children aged 0-5 years and parent/guardian/nanny care. The capacity of home-based
providers is estimated at approximately 15,000 children, and parent/guardian/nanny care capacity
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is approximately 23,000. In sum, the legal approach positioned the mandate to cover 156,000
children and not cover 118,000 children. The largest congregate care settings, which presented
the greatest risk of disease transmission, were the Article 47 childcare centers which were
covered.158
j) Potential for public backlash. Based on lessons learned from New Jersey and
Connecticut, the NYC DOHMH Bureaus of Immunization and Child Care collaborated on a plan
for a community-wide education campaign for parents, childcare providers, schools, and health
care providers to prevent public backlash. The plan included meetings at childcare facilities to
educate staff and parents, and widespread distribution of printed materials. Posters would be
developed for display in all childcare and preschool programs. In the first year of the mandate,
education would be the only means of enforcement; issuance of violation notices would begin in
the mandate’s second year. To build support, the NYC DOHMH would engage the NYC
chapters of the American Academy of Pediatrics and the American Academy of Family
Physicians, and collaborate with the Bureau of Immunization’s community advisory group, the
NYC Coalition for Immunization Initiatives.154
Enactment and Implementation
Figure 1 (page 58) shows the timeline of major activities leading to the mandate’s enactment
and implementation. The NYC DOHMH presented the proposal for the mandate to the NYC
Board of Health at the Board’s public meeting in September 2013.158 The Board agreed to move
forward with a public hearing and written comment period. The public hearing was held October
23, 2013.173 A total of 19 people commented at the hearing – all opposed.174-176 Following the
written comment period, the NYC DOHMH Deputy Commissioner for Disease Control appeared
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before the Board on December 11, 2013, to respond to the comments at the hearing and the
written comments submitted. He also presented the final proposal for the mandate.175 A total of
276 written comments had been submitted: 27 in support and 249 opposed. Those opposed
included parents, two lawyers, three autism activist organizations, and anti-vaccine advocates.
The supporters were individual physicians and several organizations, including the American
Academy of Pediatrics, the NYC Coalition for Childhood Immunization Initiatives, pro-vaccine
parent and nurse advocacy groups, including Nurses Who Vaccinate, health clinics and hospitals,
and one school. Of the comments in opposition, 127 (46%) were form letters; 62 (25%) were
from individuals who lived outside NYC.174-176
The NYC Board of Health approved the childcare vaccine mandate at the meeting on
December 11, 2013. The decision was published in the city record and took effect 30 days later
in mid-January, 2014.177 To allow sufficient time for childcare programs and parents to learn
about the mandate and prepare to comply, DOHMH began outreach and education in spring,
2014, based on the plan it had developed while deliberating the decision to seek the mandate.
Childcare and prekindergarten programs were asked to implement the new vaccine requirement
starting July 1, 2014, the beginning of the 2014-15 influenza season.
Suspension
Five NYC mothers filed suit against the mandate in November, 2015.7 The attorney
representing the mothers used the same argument that led to the suspension of the NYC
DOHMH’s soda container policy. In that case, which was decided in 2013 and upheld in June
2014, the courts ruled that the NYC Board of Health did not have the authority to enact a
requirement not specified in state law. The New York Supreme Court ruled to suspend the NYC
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childcare influenza mandate on the same grounds in a decision issued on December 16, 2015.9
NYC appealed, but lost again. In a decision issued October 6, 2016, the Appellate Court agreed
with DOHMH that the NYC Board of Health had the authority to add a vaccine requirement, but
upheld the suspension because the mandate did not apply to all NYC childcare facilities and
wrongly allowed, in their opinion, childcare facilities to opt out of excluding noncompliant
children by paying fines.10
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Aim 2 Findings: Effect of Mandate on Influenza Vaccination Rates
Population and Peak Vaccination Rates
The number of children 6-59 months of age who received > 1 influenza vaccination by
December 31 in each annual influenza season ranged from 97,568 in 2006-7 to 191,753 in 201516 (Table 1, page 63). Although the largest number of 6-59-month-olds were vaccinated in 201516, the second season of the mandate, the vaccination rate of 48.5% that season was below the
highest rate of 50.3% reached in 2009-10, the season of the H1N1 influenza pandemic. The rate
in the mandate’s second season among 6-59-month-olds was also below rates reached in two
other seasons before the mandate: 49.4% in 2010-11 and 49.1% in 2011-12. Among 5-8-yearolds, children receiving influenza vaccine ranged from 35,088 in 2006-7 to 117,047 in 2014-15,
the first season of the mandate (Table 2, page 63). The vaccination rate of 40.3% in the
mandate’s first season was also the highest rate among 5-8-year-olds across all seasons.
Vaccination Rate Trends among Children 6-59 Months and 5-8 Years
In the early seasons of 2006-7 through 2009-10, which were soon after influenza vaccine was
recommended by the Advisory Committee on Immunization Practices for all children in both age
groups, vaccination rates among 6-59-month-olds and 5-8-year-olds increased sharply (Figure 2,
page 59; Tables 1 and 2, page 63). Over the four seasons thereafter, rates among 6-59-montholds mostly declined from the peak of 50.3% in 2009-10 to 46.2% in 2013-14, the season before
the mandate. After the mandate took effect, vaccination rates among 6-59-month-olds increased
2.2 percentage points in the mandate’s first season (2014-15), and an additional 0.1 percentage
point in the mandate’s second season (2015-16), for a total increase of 2.3 percentage points to
48.5%. The average vaccination rate of two seasons before the mandate (46.1%) compared to the
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average rate of two seasons during the mandate (48.5%) indicated the mandate was associated
with a vaccination rate increase of 2.4 percentage points (Figure 3, page 60).
Among 5-8-year-olds, vaccination rates mostly increased over the four seasons before the
mandate from 32.6% in 2009-10 to 37.0% in 2013-14, a gain of 4.4 percentage points (Figure 2,
page 59; Table 2, page 63). After the mandate took effect, rates among 5-8-year-olds increased
3.3 percentage points in the mandate’s first season, followed by a decline of 1.3 percentage
points in the second season. The average vaccination rate of two seasons before the mandate
(35.1%) compared to the average rate of two seasons during the mandate (39.6%) indicated the
mandate was associated with a vaccination rate increase of 4.5 percentage points among 5-8year-olds (Figure 3, page 60).
Among both 6-59-month-olds and 5-8-year-olds, vaccination rates dropped after the
mandate’s suspension (Figure 3, page 60). The decline was greater among 6-59-month-olds.
Rates fell by 6.9 percentage points among 6-59-month-olds from 48.5%, the average rate of the
mandate’s two seasons, to 41.6% in the season after the mandate’s suspension. Among 5-8-yearolds, the same comparison showed a decline in the vaccination rate of 3.9 percentage points from
39.6% to 35.7%.
Vaccination Rate Trends among One-Year Age Groups
Figure 4 (page 61) and Tables 3-6 (pages 64-65) show vaccination rate trends among the 659-month-olds stratified by one-year age groups. Rates among the 1- and 2-year-olds mostly
declined slightly over the four seasons before the mandate. After the mandate took effect, rates
among 1-year-olds continued to decrease. The average vaccination rate of two seasons before the
mandate (54.7%), compared to the average rate of two seasons during the mandate (51.9%),
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indicated the mandate was associated with a vaccination rate decrease of 2.8 percentage points
among 1-year-olds (Figure 3, page 60). Among 2-year-olds, the average vaccination rate of two
seasons before the mandate (44.0%), compared to the average rate of two seasons during the
mandate (44.4%), indicated the mandate was associated with a slight rate increase of 0.4
percentage points (Figure 3, page 60).
Vaccination rates went slightly up and down among 3- and 4-year-olds in the four seasons
preceding the mandate (Figure 4, page 61). Rates rose in both groups after the mandate took
effect, with the steepest increases seen among 4-year-olds. The average vaccination rate of two
seasons before the mandate (43.0%), compared to the average rate of two seasons during the
mandate (54.4%), indicated the mandate was associated with a vaccination rate increase of 11.4
percentage points among 4-year-olds (Figure 3, page 60). Among 3-year-olds, the same
comparison indicated the mandate was associated with a vaccination rate increase of 5.5
percentage points from 40.7% to 46.2% (Figure 3, page 60).
Vaccination rates declined among all age groups 1-4 years after the mandate was suspended
(Figures 3 and 4, pages 60-61). The drop in rates was most pronounced among 3- and 4-yearolds. The rate among 3-year-olds declined by 10.0 percentage points from 46.2%, the average
rate of two seasons during the mandate, to 36.2% in the season after the mandate was suspended.
Based on the same comparison, the rate among 4-year-olds fell 12.1 percentage points from
54.4% to 42.3%. Among the younger groups, the same comparison showed vaccination rates
declined among 1-year-olds by 3.2 percentage points and among 2-year-olds by 5.2 percentage
points.
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Figure 5 (page 62) and Tables 7-10 (pages 66-67) show vaccination rates among 5-8-yearolds stratified by one-year age groups. Among all age groups, rates increased in the first season
of the mandate and slightly declined in the second season. Rates changed most among 8-yearolds after the mandate took effect. The average vaccination rate of two seasons before the
mandate (33.5%), compared to the average rate of two seasons during the mandate (39.6%),
indicated the mandate was associated with a vaccination rate increase of 6.1 percentage points
among 8-year-olds (Figure 3, page 60). Based on the same comparison, the mandate was
associated with an increase in rates among 5-year-olds of 4.1 percentage points, among 6-yearolds of 3.7 percentage points, and among 7-year-olds of 4.9 percentage points (Figure 3, page
60).
Vaccination rates declined moderately among all groups 5-8 years of age after the mandate
was suspended (Figure 3, page 60; Figure 5, page 62). Among 5-year-olds, the rate declined 5.3
percentage points from 41.3%, the average rate of two seasons during the mandate, to 36.0% in
the season after the mandate was suspended. The same comparison in the other age groups
showed rates fell 3.4 percentage points among 6-year-olds, 3.9 percentage points among 7-yearolds, and 3.9 percentage points among 8-year-olds.
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Figure 1. Timeline of New York City Childcare Influenza Vaccine Mandate

June 2012. Connecticut briefed New York City (NYC) Health Commissioner on increasing
vaccination rates and declining influenza-associated hospitalization rates after implementation of
Connecticut childcare influenza vaccine mandate.
June - November 2012. NYC Department of Health and Mental Hygiene (DOHMH) Bureaus
of Immunization (BOI) and Child Care (BCC) held internal meetings and collaborated with the
NYC DOHMH General Counsel on legal strategy to amend NYC Health Code. BOI reached out
to Connecticut and New Jersey to learn of experience with mandate and completed literature
review; prepared briefing for Commissioner.
December 14, 2012. Connecticut presented experience with mandate at NYC Coalition for
Immunization Initiatives.
March 2013. NYC Health Commissioner presented proposal for NYC Health Code
amendments to NYC Mayor.
September 10, 2013. NYC DOHMH BOI and BCC presented proposal for NYC Health Code
amendments to NYC Board of Health. Board approved going forward with public hearing and
posting for public comment.
October 23, 2013. NYC Board of Health held public hearing. 19 people commented – all
opposed.
December 11, 2013. NYC DOHMH Deputy Commissioner responded to comments at the NYC
Board of Health’s December meeting. A total of 276 written comments were submitted: 27 in
support and 249 opposed. Opposed were parents, two lawyers, autism activists, and anti-vaccine
advocates. Supporters were individual physicians and organizations, including the American
Academy of Pediatrics, the NYC Coalition for Childhood Immunization Initiatives, pro-vaccine
parent and nurse advocacy groups, including Nurses Who Vaccinate, health clinics and hospitals,
and one school. Of the comments in opposition, 127 (46%) were form letters; 62 (25%) were
from individuals who lived outside NYC. The NYC Board of Health voted to approve the NYC
Health Code amendments. The amendments were posted in the City Record and became
effective 30 days after meeting.
January 14, 2014. Mandate took effect. NYC DOHMH BOI and BCC started outreach and
education. Implementation began July 1, 2014.
November 9, 2015. Five NYC mothers filed lawsuit against mandate.
December 16, 2015. New York State Supreme Court suspended mandate.
October 6, 2016. State Supreme Court, Appellate Division, upheld suspension of mandate.
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Figure 2. Effects of Childcare Influenza Vaccine Mandate on Influenza
Vaccination Rates among Children 6-59 Months and 5-8 Years
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Figure 2 shows influenza vaccination rates as of December 31 in each annual influenza season
by intervention group (6-59 months) and control group (5-8 years), New York City, 2006 – 2017.
Rates were calculated based on number of children with > 1 influenza vaccination documented in
the New York City Department of Health and Mental Hygiene’s Citywide immunization
Registry divided by the Census Vintage 2016 population estimate for the age group.
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Figure 3. Vaccination Rate Change by Age Group and Period Relative to
Mandate
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Mandate Effect: Percentage point change in vaccination rate = difference between average rate
of two seasons during mandate (2014-15 and 2015-16) and average rate of two seasons before
mandate (2012-2013 and 2013-14).
Suspension Effect: Percentage point change in vaccination rate = difference between rate in the
season after suspension of mandate (2016-2017) and average vaccination rate of two seasons
during mandate.
Net Effect: Percentage point change in vaccination rate = difference between rate in season after
suspension of mandate and average rate of two seasons before mandate.
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4. Effects of Childcare Influenza Vaccine Mandate on Influenza
Vaccination Rates among One-Year Age Groups, 1-4 Years
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Figure 4 shows influenza vaccination rates as of December 31 in each annual influenza season
by one-year age groups, 1-4 years, New York City, 2006 – 2017. Rates were calculated based on
number of children with > 1 influenza vaccination documented in the New York City
Department of Health and Mental Hygiene’s Citywide immunization Registry divided by the
Census Vintage 2016 population estimate for the age group.
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Figure 5. Effects of Childcare Influenza Vaccine Mandate on Influenza
Vaccination Rates among One-Year Age Groups, 5-8 Years
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Figure 5 shows influenza vaccination rates as of December 31 in each annual influenza season
by one-year age groups, 5-8 years (control), New York City, 2006 – 2017. Rates were calculated
based on number of children with > 1 influenza vaccination documented in the New York City
Department of Health and Mental Hygiene’s Citywide immunization Registry divided by the
Census Vintage 2016 population estimate for the age group.
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Table 1. Influenza Vaccination Rates as of December 31 in Each Annual Influenza Season
among Children 6-59 Months, New York City, 2006 – 2017

Annual
Influenza
Season

2006-7
2007-8
2008-9
2009-10
2010-11
2011-12
2012-13
2013-14
2014-15
2015-16
2016-17

Children 6-59 Months with
>1 Influenza Vaccination by
12/31 Each Season

Census
Population
Estimate
(Vintage 2016)

97,568
124,246
146,411
180,791
178,128
182,851
174,172
178,516
189,666
191,753
164,221

358,803
355,422
356,956
359,560
360,940
372,502
379,512
386,061
391,605
395,091
395,091

Influenza Vaccination
Rate

27.2%
35.0%
41.0%
50.3%
49.4%
49.1%
45.9%
46.2%
48.4%
48.5%
41.6%

Table 2. Influenza Vaccination Rates as of December 31 in Each Annual Influenza Season
among Children 5-8 Years, New York City, 2006 – 2017

Annual
Influenza
Season

2006-7
2007-8
2008-9
2009-10
2010-11
2011-12
2012-13
2013-14
2014-15
2015-16
2016-17

Children 5-8 Years with >1
Influenza Vaccination by
12/31 Each Season

35,088
49,637
67,179
92,114
97,802
99,309
95,942
107,629
117,047
113,950
104,346

Census
Population
Estimate
(Vintage 2016)
275,420
274,412
277,463
282,987
286,624
286,105
288,979
290,825
290,294
292,256
292,256
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Influenza
Vaccination Rate

12.7%
18.1%
24.2%
32.6%
34.1%
34.7%
33.2%
37.0%
40.3%
39.0%
35.7%

Table 3. Influenza Vaccination Rates as of December 31 in Each Annual Influenza Season
among Children Aged 1 Year, New York City, 2006 – 2017

Annual
Influenza
Season

2006-7
2007-8
2008-9
2009-10
2010-11
2011-12
2012-13
2013-14
2014-15
2015-16
2016-17

Children Aged 1 Year with
>1 Influenza Vaccination by
12/31 Each Season

Census
Population
Estimate
(Vintage 2016)

Influenza Vaccination
Rate

38,929
47,175
54,210
63,546
61,128
63,217
60,521
61,519
59,676
59,328
56,027

103,465
102,753
103,437
104,422
105,056
108,451
110,513
112,432
114,040
115,045
115,045

37.6%
45.9%
52.4%
60.9%
58.2%
58.3%
54.8%
54.7%
52.3%
51.6%
48.7%

Table 4. Influenza Vaccination Rates as of December 31 in Each Annual Influenza Season
among Children Aged 2 years, New York City, 2006 – 2017

Annual
Influenza
Season

2006-7
2007-8
2008-9
2009-10
2010-11
2011-12
2012-13
2013-14
2014-15
2015-16
2016-17

Children Aged 2 Years with
>1 Influenza Vaccination by
12/31 Each Season

Census
Population
Estimate
(Vintage 2016)

Influenza Vaccination
Rate

27,478
34,571
40,899
53,293
49,407
51,168
48,934
49,120
51,582
50,077
45,124

103,465
102,753
103,437
104,422
105,056
108,451
110,513
112,432
114,040
115,045
115,045

26.6%
33.6%
39.5%
51.0%
47.0%
47.2%
44.3%
43.7%
45.2%
43.5%
39.2%
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Table 5. Influenza Vaccination Rates as of December 31 in Each Annual Influenza Season
among Children Aged 3 Years, New York City, 2006 – 2017

Annual
Influenza
Season

2006-7
2007-8
2008-9
2009-10
2010-11
2011-12
2012-13
2013-14
2014-15
2015-16
2016-17

Children Aged 3 Years with Census
>1 Influenza Vaccination by Population
12/31 Each Season
Estimate
(Vintage 2016)
20,937
28,392
34,178
43,237
44,803
44,677
42,538
44,224
49,377
51,780
39,798

101,248
99,944
100,055
100,478
100,553
103,733
105,658
107,464
109,016
110,001
110,001

Influenza Vaccination
Rate

20.7%
28.4%
34.2%
43.0%
44.6%
43.1%
40.3%
41.2%
45.3%
47.1%
36.2%

Table 6. Influenza Vaccination Rates as of December 31 in Each Annual Influenza Season
among Children Aged 4-4.5 Years, New York City, 2006 – 2017

Annual
Influenza
Season
2006-7
2007-8
2008-9
2009-10
2010-11
2011-12
2012-13
2013-14
2014-15
2015-16
2016-17

Children Aged 4-4.5 Years
with >1 Influenza
Vaccination by 12/31 Each
Season

Census
Population
Estimate
(Vintage 2016)

10,224
14,108
17,124
20,715
22,790
23,789
22,179
23,653
29,031
30,568
23,272

50,624
49,972
50,028
50,239
50,276
51,867
52,829
53,732
54,508
55,000
55,000
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Influenza Vaccination
Rate

20.2%
28.2%
34.2%
41.2%
45.3%
45.9%
42.0%
44.0%
53.3%
55.6%
42.3%

Table 7. Influenza Vaccination Rates as of December 31 in Each Annual Influenza Season
among Children Aged 5.5 - <6 years, New York City, 2006 – 2017

Annual
Influenza
Season
2006-7
2007-8
2008-9
2009-10
2010-11
2011-12
2012-13
2013-14
2014-15
2015-16
2016-17

Children Aged 5.5 - <6
Years with >1 Influenza
Vaccination by 12/31 Each
Season
6,790
9,684
12,802
16,926
17,693
17,454
17,005
18,893
20,216
19,815
17,524

Census
Population
Estimate
(Vintage 2016)
45,903
45,735
46,244
47,164
47,771
47,684
48,163
48,471
48,382
48,709
48,709

Influenza Vaccination
Rate

14.8%
21.2%
27.7%
35.9%
37.0%
36.6%
35.3%
39.0%
41.8%
40.7%
36.0%

Table 8. Influenza Vaccination Rates as of December 31 in Each Annual Influenza Season
among Children Aged 6 Years, New York City, 2006 – 2017

Annual
Influenza
Season

2006-7
2007-8
2008-9
2009-10
2010-11
2011-12
2012-13
2013-14
2014-15
2015-16
2016-17

Children Aged 6 Years with Census
>1 Influenza Vaccination by Population
12/31 Each Season
Estimate
(Vintage 2016)
12,264
17,128
23,370
31,980
33,550
34,004
32,996
37,376
39,370
38,438
35,771

91,807
91,471
92,488
94,329
95,541
95,368
96,326
96,942
96,765
97,419
97,419
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Influenza Vaccination
Rate

13.4%
18.7%
25.3%
33.9%
35.1%
35.7%
34.3%
38.6%
40.7%
39.5%
36.7%

Table 9. Influenza Vaccination Rates as of December 31 in Each Annual Influenza Season
among Children Aged 7 years, New York City, 2006 – 2017

Annual
Influenza
Season

2006-7
2007-8
2008-9
2009-10
2010-11
2011-12
2012-13
2013-14
2014-15
2015-16
2016-17

Children Aged 7 Years with Census
>1 Influenza Vaccination by Population
12/31 Each Season
Estimate
(Vintage 2016)
10,830
15,406
20,644
29,013
31,409
31,701
30,445
34,414
38,093
36,596
33,645

91,807
91,471
92,488
94,329
95,541
95,368
96,326
96,942
96,765
97,419
97,419

Influenza Vaccination
Rate

11.8%
16.8%
22.3%
30.8%
32.9%
33.2%
31.6%
35.5%
39.4%
37.6%
34.5%

Table 10. Influenza Vaccination Rates as of December 31 in Each Annual Influenza Season
among Children Aged 8-8.5 years, New York City, 2006 – 2017

Annual
Influenza
Season

2006-7
2007-8
2008-9
2009-10
2010-11
2011-12
2012-13
2013-14
2014-15
2015-16
2016-17

Children Aged 8-8.5 Years
with >1 Influenza
Vaccination by 12/31 Each
Season

Census
Population
Estimate
(Vintage 2016)

5,204
7,419
10,363
14,195
15,150
16,150
15,496
16,946
19,368
19,101
17,406

45,903
45,735
46,244
47,164
47,771
47,684
48,163
48,471
48,382
48,709
48,709
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Influenza Vaccination
Rate

11.3%
16.2%
22.4%
30.1%
31.7%
33.9%
32.2%
35.0%
40.0%
39.2%
35.7%

Section 5: Discussion and Conclusions
Summary of Results: Aims 1 and 2
The NYC DOHMH spent over a year deliberating its decision to seek a childcare influenza
vaccine mandate. Its efforts to advocate for a change in state law to require influenza vaccine for
childcare statewide were unsuccessful. NYC DOHMH asked the NYC Board of Health to amend
the NYC Health Code to enact the mandate only after careful consideration of the mandate’s
potential health and economic impact. The decision was informed by a thorough literature review
and extensive information-gathering from the states of Connecticut and New Jersey, the only
other jurisdictions in the US to mandate influenza vaccine for childcare. Strong evidence
indicated the mandate would raise influenza vaccination rates among children younger than 5
years, thereby protecting an age group at high risk of serious complications from influenza.12 The
increase in vaccination rates among young children was also expected to reduce communitywide transmission of influenza. Other high risk groups, including infants too young to be
vaccinated, people with chronic health conditions, and those 65 years of age or older were
expected to be better protected from the potentially deadly disease after the mandate.
NYC faced a challenge not confronted by the other jurisdictions. As a city, not a state, NYC
needed to find a legal solution to add an immunization requirement for childcare that would
normally be accomplished by changing state law. The DOHMH General Counsel crafted a legal
strategy for applying the mandate to city-regulated childcare and prekindergarten facilities only.
The strategy was well-justified from a public health perspective. These facilities included the
largest childcare programs, which would pose the highest risk to children for acquiring influenza
due to the large numbers of children in attendance.158-159
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NYC DOHMH’s legal approach met the approval of the NYC Board of Health but did not
stand up in the courts. The New York State Supreme Court suspended the mandate mid-way
through its second season in response to a lawsuit filed by five NYC mothers.9 The State
Supreme Court ruled that the NYC Board of Health did not have the authority to mandate a
vaccine not required by state law. NYC appealed, but the Appellate Court upheld the suspension
for different reasons than the one cited by the State Supreme Court. The Appellate Court judges
agreed with NYC DOHMH that the NYC Board of Health was authorized to mandate the
vaccine. They maintained the suspension because the mandate did not cover all childcare
facilities in the NYC and, in their opinion, wrongly allowed childcare operators to opt out of the
vaccine requirement by paying fines.10 NYC DOHMH is preparing a second appeal which will
be filed soon.
The mandate’s suspension appears not to have undermined the public’s confidence in
vaccines in general. NYC’s vaccination rates for routine childhood and adolescent vaccines are
stable or increasing.103 With only one season after the mandate available for examination, it is
too soon to tell whether the suspension inflicted long-term damage on acceptance of influenza
vaccine for young children in NYC. Research has shown that some health care providers do not
routinely recommend influenza vaccine for their pediatric patients.178 Education is needed to
counter common misconceptions held by providers and parents, e.g., influenza is not a serious
disease, influenza vaccine causes influenza, and influenza vaccine is not safe or effective.178
The quantitative analysis in this study indicated the NYC childcare influenza mandate had
little impact on increasing influenza vaccination rates among the aggregate group of 6-59-montholds. The average vaccination rate of two seasons before the mandate (46.1%), compared to the
average rate of two seasons during the mandate (48.5%), indicated the mandate was associated
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with a vaccination rate increase of only 2.4 percentage points among all NYC 6-59-month-olds.
This increase fell short of NYC’s expectations that vaccination rates would rise by 4.6
percentage points among all 6-59-month-olds in response to the mandate.
Among 5-8-year-olds, who were not covered by the mandate, vaccination rates increased 4.5
percentage points during the mandate. This may have been an indirect effect of the mandate or
due to other factors. The possibility of a sibling effect, whereby children in the 5-8 year-old
group were vaccinated because a sibling in the 6-59-month-old group was required to receive
vaccine, was investigated and ruled out. Siblings in both age groups were removed from the
analysis and vaccination rate trends remained the same (data not shown).
After the mandate’s suspension, influenza vaccination rates among 6-59-month-olds fell 6.9
percentage points, a larger decrease than the 3.9 percentage point decline seen among 5-8-yearolds. The greater decrease in the vaccination rate among 6-59-month-olds may suggest an effect
of the mandate. It is possible that the mandate propped up vaccination rates among 6-59-montholds, which were slightly declining over the four seasons before the mandate. When the
mandate’s support was removed, rates plummeted.
The stratified analysis by one-year age group showed that the influenza vaccination rate
among 4-year-olds increased 11.4 percentage points. This was by far the largest increase among
all age groups, suggesting the mandate succeeded for 4-year-olds. The 12.1 percentage point
drop in the vaccination rate among 4-year-olds after the mandate’s suspension was also the
largest post-mandate change in rate among all age groups, further supporting an effect of the
mandate among 4-year-olds. The rate among 3-year-olds increased by 5.5 percentage points
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during the mandate, and fell 10.0 percentage points after the mandate’s suspension, indicating
the mandate may have also affected 3-year-olds.
The mandate’s larger effect among 3- and 4-year-olds is supported by evidence showing that
a greater proportion of children in these age groups attend licensed childcare and prekindergarten
compared to 1- and 2- year-olds. Children 4 years of age are the largest single age group in
childcare and preschool programs for children younger than 6 years of age.179 Further, in NYC,
the implementation of the childcare influenza vaccine mandate coincided with Mayor de Blasio’s
initiative for expanding universal prekindergarten.180 These publicly funded programs are
available for free to families of all NYC children turning 4 years of age in the calendar year.
Hence, more 3- and 4-year-olds were entering prekindergarten and would have been directly
affected by the influenza vaccine mandate.
Among 5-8-year-olds, the vaccination rate rose 6.1 percentage points in 8-year-olds during
the mandate, the largest increase among all one-year age groups except 4-year-olds. The decline
in vaccination rate after the mandate’s suspension among 8-year-olds (3.9 percentage points),
compared to the decline among 3-year-olds (10.0 percentage points) and 4-year-olds (12.1
percentage point), does not support an impact of the mandate on 8-year-olds, however.
An interesting question is why, during the mandate, NYC’s influenza vaccination rates did
not appear to reach the high levels seen in Connecticut and New Jersey. One important factor to
consider is that different data and methods were used to measure vaccination rates in this study
as compared with those used by the two states. The rates in Connecticut and New Jersey were
based on the NIS-Flu Survey, while NYC’s rates in this study were based on its Citywide
Immunization Registry. NIS-Flu data for NYC shows different rate levels and increases in rates
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than seen in the results of this study. (Note that NIS-Flu data is based on a random digit dial
telephone survey and vaccinations reported are not verified against medical records.156 Citywide
Immunization registry data are reported by health care providers, primarily from electronic
medical records. NIS-Flu is based on a random sample, while the population in this study
included all children who met the no aging in or out criteria and who had received one or more
influenza vaccinations during July 1 – December 31 each season that were documented in the
Citywide Immunization Registry).
From 2013-14, the season before NYC’s mandate and the first season in which NYC-specific
estimates were available from NIS-Flu, the influenza vaccination rate among NYC 6-59-montholds as of May increased 6.5 percentage points from 73.6% (CI = 67.0% - 80.2%) to 80.1% (CI =
75.2% - 85.0%) in 2015-16,156 the second season of NYC’s mandate. This is a larger increase
than the 2.3 percentage points rise seen among NYC 6-59-month-olds in this study based on a
comparison of the same two seasons. The increases observed in NIS-Flu data were not
significant, however, because of overlapping confidence intervals.
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Ethics Analysis: Application of Conceptual Frameworks
Kass Framework
In the following pages, Kass’s six-question framework23 is adapted to the NYC childcare
influenza vaccine mandate to guide an ethics analysis of the mandate. Questions are answered
based upon the results of the record review and analysis of vaccination rate changes before,
during, and after the mandate.
1. What were the public health goals of the NYC childcare influenza vaccine mandate?
The goal of the NYC mandate was to increase influenza vaccination rates among 6-59-montholds attending childcare. NYC DOHMH set the target of a 4.6 percentage point increase in
influenza vaccination rates among all 6-59-month-olds. The increase in vaccination rates was
expected to accelerate progress toward herd immunity against influenza which would protect
individual children, their families, and the broader community against the potentially deadly
disease.
The mandate specifically required children attending city-regulated childcare and preschool to
receive influenza vaccine during the period of July 1 through December 31 each year.177 This
timeframe was specified because influenza activity tends to increase in October and peak
between December and January.163 Influenza viruses may still circulate through May.163 The
mandate called for vaccination by December 31 to protect children, families and the community
against influenza earlier in the season and for a longer period within each annual season.
Because evidence has shown that children younger than 5 years are at high risk for serious
complications from influenza,12-13 attack rates for influenza among this age group are high (i.e.,
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35% to 45%),161 and that influenza vaccines are effective among children older than 2 years 167
(the majority of children attending childcare and preschool are 4 years of age 179), the public
health goals of the mandate may be considered ethical and justified. Detracting from the
justification somewhat was that most of the evidence for effectiveness of vaccinating children to
achieve herd immunity was based on school-aged children.154 Studies focusing on pre-schoolaged children are needed to examine the impact of vaccinating children younger than 5 years on
herd immunity against influenza.

2. How effective was the mandate in achieving its stated goals?
Influenza vaccination rates among all NYC 6-59 months-olds increased 2.4 percentage points
during the mandate, short of DOHMH’s 4.6 percentage point target. Rates among 4-year-olds
increased 11.4 percentage points, however, suggesting the mandate was effective for this age
group. The results of this study also suggest that the mandate may have indirectly brought up
vaccination rates among 5-8-year-olds. Rates among all 5-8-year-olds rose 4.5 percentage points
during the mandate, with the largest increase seen among 8-year-olds at 6.1 percentage points. It
is also possible that the mandate propped up rates among 6-59-month-olds, which were trending
slightly downward before the mandate, and dropped precipitously by 12.1 percentage points after
the mandate’s suspension. These findings lend support to the conclusion that the mandate was
ethical and justified based on its success, particularly among 4-year-olds.
3. What were the known or potential burdens of the mandate?
The main burdens of the childcare influenza vaccine mandate were: (1) curtailment of
parental autonomy; (2) exposing children to potential health risks from influenza vaccines; and
(3) costs, both monetary and time and effort, borne by parents to assure their children receive
influenza vaccine between July 1 and December 31 of each year or to comply with
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administrative procedures for obtaining a medical or religious exemption. Burdens were also
imposed upon childcare and prekindergarten programs, and public health, to implement and
enforce the mandate. Influenza, unlike other vaccines, must be received annually so efforts to
comply with the mandate on the part of parents, childcare and prekindergarten programs, and
public health must be undertaken every year. Burdens are further described below.
4. Can burdens be minimized? Are there alternative approaches?
(1) Autonomy. The parents who brought the lawsuit against NYC’s childcare influenza
vaccine mandate argued that they should have the right to decide against vaccinating their child.
If this decision were to affect only themselves and their own child, this argument would be
convincing. But because the effectiveness of vaccines relies on herd immunity, which requires a
majority of individuals to be vaccinated, a parent’s decision to accept vaccine affects other
children, families, and the community. Reaching a high vaccination rate is especially important
to protect infants too young to be vaccinated, people who cannot be vaccinated because their
immune systems are compromised by cancer or other chronic disease, and elderly people who
may not mount an adequate immune response to the vaccine. Consequently, it is important for
healthy children who can be vaccinated to receive the vaccine. Parents who refuse a vaccine for
their child, but look to other parents to accept vaccine to protect their own unvaccinated child
through herd immunity, are unjust “free riders.” The health risks of influenza vaccine, though
very small, must be fairly shared along with the vaccine’s benefits.
The burden of limiting parental autonomy may be reduced, however, by allowing a parent to
obtain a legitimate exemption from the influenza vaccine requirement. The childcare influenza
vaccine mandate did not change the existing policy for exemptions from vaccine requirements.
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Exemptions are approved when a child has a physician-verified medical condition that could
result in injury from influenza vaccine or the family demonstrates sincerely held religious beliefs
in opposition to the vaccine. In New York State, a parent may request a medical or religious
exemption; philosophical or personal belief exemptions are not permitted.33, 37
(2) Health risks. The risks of influenza disease are far higher than the risks of influenza
vaccination. As with all vaccines, influenza vaccines are subject to pre-licensure clinical trials
and post-licensure monitoring of adverse events to maximize their safety and efficacy.51
Influenza vaccines are considered very safe, but adverse events related to influenza
vaccination do occur. Adverse events following vaccination are generally categorized by
frequency (common, rare), extent (local, systemic), severity (hospitalization, disability, or death),
causality, and preventability (intrinsic to vaccine, faulty production, faulty administration).51
Such events may be coincidental with vaccination or vaccination may be causally related.
Examples of common local adverse reactions to influenza vaccine are soreness, swelling, and
redness at the site of injection. Systemic problems are also known to occur after influenza
vaccination and include fever, headache, and fatigue. Most local and systemic reactions are mild
and go away on their own after 1 or 2 days. Serious problems following influenza vaccination
such as Guillain-Barre Syndrome or a life-threatening event, such as an acute allergic reaction
(anaphylaxis) to a vaccine, are very rare. Estimates are they occur with 1 in 1million doses and
can be minimized by screening.51, 181 People who believed they may have been harmed by a
vaccine may file a claim for compensation through the National Vaccine Injury Compensation
Program. This program was established by the Vaccine Injury Compensation Act of 1986.53
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(3) Costs: Financial, Time, and Effort
As described earlier, the financial burden of childhood vaccination has been reduced by the
Vaccines for Children (VFC) Program.59 Under VFC, the federal government purchases vaccines
and collaborates with state and local health departments to distribute them to health care
providers at no cost for administration to children 0-18 years of age who are covered by
Medicaid or are uninsured, underinsured, or American Indian/Alaska Native. Vaccines
purchased by states such as New York are also distributed through VFC to providers to vaccinate
children covered by the State Child Health Insurance Programs.59 The cost of vaccination has
been further reduced for NYC children by the enactment of a state law requiring health insurance
written in New York State to cover all vaccines recommended by the Advisory Committee on
Immunization Practices for children 0-18 years.60 Further, the NYC DOHMH distributes
vaccines purchased with public funding to all NYC providers participating in VFC for
underinsured children so they may be vaccinated in their medical homes. {Per VFC policy,
underinsured children may receive vaccines purchased with VFC funds only in a Federally
Qualified Health Center (FQHC) or at a FQHC-delegated provider.59}
Further improvements in access to influenza vaccines, in particular, are needed, however.
Because influenza vaccine is needed every year, parents must spend time and effort to take their
children to a medical provider for influenza vaccine year in and year out. This added burden may
be relieved by expanding school-based health centers and school-located vaccination programs
in schools with pre-kindergarten classes so parents can avoid having to take off from work to
visit a health care provider. Allowing children to be vaccinated at pharmacies would also ease
the burden since these sites may be more conveniently located and open on nights and weekends
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outside of work hours. Currently, New York State allows pharmacists to vaccinate only adults
aged 18 years and older.182
Alternatives. As described in this paper’s literature review, there are a range of theoryinformed and evidence-based interventions for raising vaccination rates. The NYC DOHMH
uses these interventions up to the limit of its resources, which have declined over the years as
public health funding has fallen. Despite DOHMH’s efforts, influenza vaccination rates were
decreasing among 6-59-month-olds over the four influenza seasons preceding NYC’s childcare
influenza vaccine mandate. In light of the trend, an attempt to raise influenza vaccination rates
with a mandate was ethical and justified. Some argue that vaccine mandates may not be
necessary in a society in which the health care system covers everyone and emphasizes
prevention.16-17 The US fails to meet these criteria, so vaccine mandates will likely still be needed
to reach high vaccination rates in the future.
5. Was the mandate implemented fairly?
The childcare influenza vaccine requirement may be considered fair in that it applied to all
children attending city-regulated childcare and prekindergarten in NYC. Children attending
state-regulated and unregulated childcare were not covered by the mandate, a reasonable
decision given NYC would not be in the same position to enforce the mandate in those facilities.
It would have been fairer for all facilities to have been covered, but the practical reality was that
the DOHMH needed to implement and enforce the mandate and it determined it could not do so
in facilities it does not regulate. In addition, DOHMH was not able to require the public schoolbased prekindergarten programs to exclude unvaccinated children because the influenza vaccine
requirement was not in state law. Hence, enforcement was not uniform across covered facilities.
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The better and fairer approach would have been for all facilities to exclude unvaccinated
children, but this was also not possible from a practical standpoint. Further, enforcement may
have been inconsistent among the covered facilities because resources available for this purpose
in the DOHMH and among childcare program staff were likely limited.
6. How could the benefits and burdens of the mandate be fairly balanced?
The benefits of the influenza vaccine mandate are fairly balanced against the burdens when
the vaccine is easily available, safe, and effective. Major strides toward achieving broad access
to vaccines have been made with the VFC program. Influenza vaccines currently have a strong
safety record and are known to be effective in children older than 2 years.51, 167 Efforts to ensure
influenza vaccine safety and effectiveness must continue. Insufficient research has been done on
influenza vaccine effectiveness among children younger than 2 years. Studies on this important
subject are needed.167
The NYC childcare influenza vaccine mandate was enacted by the NYC Board of Health,
whose members were appointed by democratically elected mayors. Community involvement in
the decision-making took place through a public hearing and written comment period.
Considering that only 276 written comments were received, public participation was very low.
Efforts to encourage public participation in Board of Health decision-making are needed.
Conclusions. The above analysis supports the conclusion that the NYC childcare influenza
vaccine mandate, which was intended to protect individual children and communities against a
serious diseases, was ethical because it was enacted through a democratic process, applied to all
NYC children age 6-59 months in city-regulated childcare and prekindergarten, allowed for

79

exemptions for legitimate medical or religious reasons, and was effective at increasing
vaccination rates among 4-year-olds, the largest age group in childcare and prekindergarten.179
Field and Caplan Framework
This framework facilitates an analysis of the ethics of vaccine mandates based on competing
ethical values of autonomy, beneficence, utilitarianism, justice, and nonmaleficence in the
context of disease severity. Autonomy is a cherished American value that, when applied to
childhood vaccine mandates, holds that the right to make a decision about vaccinating a child
rests with that child’s parent.24 The parent has the right to liberty, meaning the parent should be
free from government coercion. The parent must also have agency: the ability to understand the
consequences of an action or the alternatives to action. Beneficence is the moral imperative to act
for the benefit of another and emphasizes the best outcome for the individual. Utilitarianism
focuses on the best outcome for the greatest number of people. Justice calls for fair distribution
of scarce goods, requiring equal access to vaccines. The VFC program is an important means of
facilitating equitable access by reducing cost barriers to vaccines. In the case of a medical
intervention such as vaccination, justice also requires health risks to be fairly distributed among
members of the community. Nonmaleficence is a directive against harming others, requiring
vaccines to be generally safe for the majority of people.24
Autonomy takes precedence when an individual’s action causes no harm to himself or others.
As the risk of harm from a severe disease such as influenza increases, the importance of
autonomy declines. Beneficence and utilitarianism become more prominent. Children younger
than 5 years are at high risk of serious complications from influenza, and influenza attack rates in
this age group are high.12, 161 In this context, beneficence supports vaccination to protect the
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individual child. Utilitarianism supports a mandate to require widespread vaccination to protect
the community.24
The NYC childcare influenza vaccine mandate was just in that it provided for the risks of
influenza vaccination, although small, to be equally shared among all children attending cityregulated childcare and prekindergarten. The unjust “free rider” outcome, occurring when a
parents chooses not to vaccinate a child and instead relies on herd immunity based on risks borne
by other children, is avoided in the context of a vaccine mandate. The childcare influenza
mandate also met the directive for nonmaleficence because influenza vaccine has a strong safety
record among children.12-13, 51-52
Conclusion. An analysis of the NYC childcare influenza vaccine mandate using the Field
and Caplan framework demonstrates that the mandate was ethical. In the authors’ graphic (page
91), the NYC mandate would fall in the lower right, based on the NYC DOHMH’s obligation for
utilitarianism, beneficence, justice, and nonmaleficence taking precedence over parental
autonomy in the context of the potentially severe disease of influenza.
Limitations
The quantitative analysis for Aim 2 used a short interrupted time-series design, and
administrative data from the Citywide Immunization Registry. Consequently, the study was
subject to the limitations of these methods and data, as described below.
Interrupted Time-Series. Biases typically affecting the results of interrupted times-series
studies are history, maturation, selection bias, instrumentation, cyclical or seasonal patterns,
duration of the intervention, random fluctuations in data points, and autocorrelation of data, i.e.,
the tendency for data collected at consecutive time points to be dependent on each other.112
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Autocorrelation, or serial dependency, of time-series data is common Consequently, ordinary
statistics may not be used because they assume observations are independent of each other.112
(Techniques are available to take autocorrelation into account in interrupted time-series studies
with a sufficient number of data points.) This study encountered challenges in completing a valid
statistical analysis; details are described in the later section entitled Citywide Immunization
Registry Data.
Perhaps the greatest threat to internal validity is history,112 i.e., the potential for factors other
than the mandate to influence influenza vaccination rates among 6-59-month-olds at the same
time the mandate was in effect. Examples of such factors are annual variation in severity of the
influenza season, media coverage of pediatric deaths from influenza, the timing of availability of
influenza vaccine, and whether the vaccine was a good match for the circulating virus strains.
To reduce validity threats, the study design included the use of a control group, the 5-8-yearolds. Vaccination rates among the control group, who were not directly affected by the mandate,
would be expected to respond to many validity threats in the same way as they would among 659-month-olds.
Non-equivalent Control Group. It should be acknowledged that the control group of
children 5-8 years of age differs from the 6-59 month-old intervention group in several notable
respects. Children younger than 5 years of age are at higher risk for influenza-association
complications, which may motivate health care providers to prioritize influenza vaccination of
the 6-59-month-olds over that of the 5-8-year-olds. The Advisory Committee on Immunization
Practices recommended annual influenza vaccination for 6-23-month-olds in 2004,130 and for 2459-month-olds in 2006,131 while expansion of the recommendation to all children 6 months of
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age and older was issued in 2008.132 Longer-standing recommendations are often associated with
higher vaccination rates.
Younger children typically visit health care providers more often to receive other vaccines
within the first 2 years of life and at 4-5 years of age before starting school.36 Children older than
5 years are not typically due for other routine vaccinations, unless they are behind schedule, until
age 11 years.36 Consequently, the 6-59-month-olds have more opportunities to receive influenza
vaccine during those visits. Co-administration of all recommended vaccines due at a visit is
strongly encouraged. On the other hand, the 5-8-year-olds are of school-age and therefore likely
to be in congregate settings while children younger than 5 years may still be cared for at home.
These differences between the two age groups were not expected to change in response to the
mandate, however, so they should not be considered a threat to a valid comparison of vaccination
rates between the two groups.
Citywide Immunization Registry Data
Missing variable. There is no variable in the Citywide Immunization Registry indicating
which children are in childcare and pre-kindergarten. A comparison of vaccination rates among
6-59-month-olds in childcare or prekindergarten to those not attending these programs is not
possible using Citywide Immunization Registry data alone. Hence, the change in influenza
vaccination rates among all NYC 6-59-month-olds was the primary outcome variable.
Population data versus sample and statistical analysis. Some researchers consider data
from immunization information systems such as the Citywide Immunization Registry to be
population data, and therefore do not conduct statistical analyses when using these data.
However, data in these systems do not meet the full definition of population data. Even for well83

established systems like the Citywide Immunization Registry, which is estimated to capture over
90% of immunizations administered to NYC children,103 some vaccination providers do not
report 100% of vaccinations administered. Further, denominators are inflated by out-migration
and duplicate records, necessitating use of census population estimates as denominators for
vaccination rate calculations. (See details in Denominator measurement section.)
The Citywide Immunization Registry data used in this study was also not a random sample,
and the size of the study population was very large. Chi-square tests comparing vaccination rate
changes before and during the mandate among one-year age groups were all highly significant
due to population size (data not shown). Other statistical methods were explored but were not a
good fit for the data. There were too few data points in the time series to use segmented
regression or Joinpoint software, and a difference in differences analysis was ruled out because
vaccination rate trends among the intervention and control groups were not parallel before the
mandate. Consequently, it was not possible to complete a meaningful statistical analysis of
vaccination rate changes in this study.
Denominator measurement. The Citywide Immunization Registry, as with all
immunization information systems, is challenged by determining an accurate denominator to
measure proportion of children vaccinated. The main problem is that all children born in NYC
are automatically enrolled with birth certificate information in the Citywide Immunization
Registry but many may move away and the Citywide Immunization Registry is not notified.
Providers have the capability of indicating in the Citywide Immunization Registry that children
have moved or gone elsewhere (MOGE), but most don’t because they do not know or will not
take the time to indicate it. Hence, these children remain in the denominator. The extent of this
problem is not fully known and requires study.
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A further challenge to determining an accurate denominator is duplicate (i.e., unmatched)
records. In the Citywide Immunization Registry, duplicate records are estimated at between 5%
and 10% of all patient records.103 The creation of duplicate records may be more common when
influenza vaccinations are reported because children may receive influenza vaccine outside of
their regular medical home and the vaccination is reported with minimal identifying information,
preventing matching. The combination of the MOGE and duplicate records challenges results in
inflated denominators. Researchers using immunization information system data often use
census denominators for calculations of vaccination rates.
In this study, the Census Vintage 2016 population estimates were used for denominators in
calculations of influenza vaccination rates. These estimates show an increase in the number of
children in the younger age groups, which had the effect of lowering vaccination rates calculated
for those groups. It is not clear at this time whether the estimates are accurate. The number of
births in NYC has not increased during the study period, however, but rather has declined.183 An
increase in the size of the younger age groups would need to have resulted from a net inmigration of families with young children and/or an increase in families with young children
born in NYC remaining in NYC. Based upon past experience, the US Census Bureau considers
the vintage population estimates to be very accurate. The average absolute difference between
the final total resident population estimates from 2000 to 2010 and the 2010 Census counts was
only 3.1%.144 Given the large sample size in this study, and the low error rate expected for the
Census Vintage 2016 population estimates, future adjustments to the vaccination rate
calculations in this study will likely change the vaccination rate estimates very little. The rates
will be higher if the population estimates are reduced. If the adjustments are small, however, and
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fairly even across the years, the vaccination rate trends observed in this study will remain
unchanged. Hence, this study’s findings will likely remain the same.
Reporting bias. There may be reporting bias in Citywide Immunization Registry data related
to the linking of publicly purchased vaccine distribution to Citywide Immunization Registry
reporting.141 Nearly 80% of pediatric immunizing providers in NYC participate in the Vaccines
for Children (VFC) program,147 which distributes vaccines to providers at no cost for
administration to children of low income families.59 When the provider orders VFC vaccine from
the NYC DOHMH, the number of doses the provider received from VFC previously is compared
to the number of doses the provider reported administering to eligible children. Providers who
reported less than 80% of vaccine doses as having been administered to eligible children may
have their orders reduced.141 Providers may therefore be more likely to report vaccinations
administered to VFC-eligible children than to privately insured patients. The majority of NYC
children are eligible for vaccines distributed through VFC, however. Approximately 74% of
NYC children 0-18 years of age meet eligibility criteria for publicly purchased vaccines.103, 141
Moreover, most providers are reporting through their electronic health records and these systems
send all documented vaccinations to the Citywide Immunization Registry whether the child is
eligible for VFC or is privately insured.136
DOHMH is aware that some providers, in particular those who do not participate in the VFC
program, are not reporting to the Citywide Immunization Registry. These providers are
contributing to bias in the data because their patients’ vaccinations are not in the Citywide
Immunization Registry. Unfortunately, DOHMH lacks the leverage that VFC vaccine
distribution offers to incentivize reporting by these providers, other than the threat of fines for
violating the NYC Health Code and State law. DOHMH resources for enforcement are very
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limited, making it possible for some providers to remain noncompliant. The bias introduced by
providers who do not report to the Citywide Immunization Registry is not expected to be a
serious threat to internal validity of the interrupted time-series study, however. This is because
the lack of reporting is not expected to differentially affect 6-59-month-olds compared to 5-8year-olds or to have changed from 2011 forward. Further, the number of non-reporting providers
is estimated to be less than 10% of all childhood immunizing providers in NYC.
Citywide Immunization Registry data may also be subject to bias related to underreporting of
influenza vaccinations by providers who report regularly. Influenza vaccinations, in particular,
are thought to be less well reported to the Citywide Immunization Registry than other
vaccinations. One possible reason is that providers may offer influenza vaccine during special
clinics held outside of their regular workflow and do not document influenza vaccination in the
child’s electronic health record so the vaccination does not get reported to the Citywide
Immunization Registry. The extent of underreporting is not known and is not expected to
differentially affect 6-59-month-olds compared to 5-8-year-olds.
Generalizability
This study was based on NYC data alone so generalizability may be limited. The results may
be generalizable to other cities or jurisdictions similar to NYC. The findings and lessons learned
contribute to the knowledge base related to the effectiveness of childcare vaccine mandates and
factors to consider when weighing the pros and cons of mandating a childhood vaccine.
Lessons Learned
The results of this study add to the evidence base showing that childcare vaccine mandates
are effective at raising vaccination rates. The results also confirm that a childhood vaccine
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mandate, even when carefully deliberated and planned, can prompt powerful pushback. As few
as five parents, along with a savvy lawyer who knew how to exploit the recent soda container
ruling, were able to negate all of NYC DOHMH’s efforts to put the mandate in place. The gains
in influenza vaccination rates realized from NYC’s mandate among 4-year-olds were quickly lost
– in their entirety -- after the mandate’s suspension.
Conclusions
This study found that NYC’s rationale for the childcare influenza vaccine mandate was strong
and carefully deliberated. Based upon the evidence of health and economic burdens of influenza,
the increase in vaccination rates reported by New Jersey and Connecticut, and the support of
pediatricians, nurses, and pro-vaccine parents, NYC’s decision to seek the mandate was justified.
The mandate was also ethical based on the application of both the Kass and Field and Caplan
conceptual frameworks. An important factor was that the mandate was successful in raising
vaccination rates among 4-year-olds, the largest age group in childcare and prekindergarten.179
An interesting question is whether the NYC DOHMH made the right decision to seek the
mandate from the NYC Board of Health, given the mandate’s suspension and the loss of all gains
in influenza vaccination rates among 4-year-olds. The answer is complicated by several factors.
The advantage of asking the NYC Board of Health to enact the influenza vaccine requirement
was that the Board is made up of public health experts who are more likely to make decisions
based on scientific evidence rather than political concerns, compared to the New York State
Legislature. The Board enacted the mandate within a few short months of its introduction. In
contrast, years of efforts to persuade the New York State Legislature to add the childcare
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influenza vaccine requirement have not progressed beyond getting a bill introduced in
committee.
There were several disadvantages to seeking the mandate from the NYC Board of Health,
however. First, NYC’s mandate was vulnerable to a court challenge because it was enacted soon
after the NYC Board of Health’s authority was undercut by the soda container court decision. A
further complicating factor was that while it made sense to apply the mandate to only childcare
facilities regulated by NYC, since NYC was able to enforce the mandate in these facilities, this
decision amplified the mandate’s vulnerability to a legal challenge because it did not cover all
childcare facilities in NYC. In addition, because the mandate was enacted by a change to the
NYC Health Code and not a change in state law, differential enforcement between the private
childcare and prekindergarten programs and public school-based prekindergarten programs
occurred. The NYC DOHMH was able to require the private programs to exclude noncompliant
children, while the NYC Department of Education had the ability to decide against excluding
noncompliant children in public prekindergarten because the vaccine requirement was not
included in state law. The more effective and equitable approach would have been for all
childcare and prekindergarten programs to enforce the vaccine requirement by excluding
noncompliant children.
Despite the mandate’s suspension, enacting the mandate may be considered the right decision
in that it gave NYC the opportunity to demonstrate the mandate’s effectiveness in increasing
influenza vaccination rates among 4-year-olds, the largest age group in childcare and
prekindergarten.179 This evidence strengthens the argument for a childcare influenza vaccine
requirement statewide and may help to move the proposal for state law change forward. In the
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absence of such a change, however, alternatives to a vaccine mandate for increasing influenza
vaccination rates among young children in NYC are needed.
Directions for Future Research
This study pointed to gaps in research related to influenza vaccination of children. The
effectiveness of influenza vaccine among children younger than 2 years requires more research.
The impact of vaccinating children younger than 5 years of age against influenza to produce herd
immunity against the disease is not known and needs study. Finally, in light of NYC’s
experience, research is needed to identify interventions to increase influenza vaccination rates
among young children in the absence of a vaccine mandate.
Human Subjects
The Institutional Review Boards of the New York City Department of Health and Mental
Hygiene and City University of New York determined that this study was exempt from the
federal regulations under 45 CFR §46.101 (b)(4).
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Diagram 2. Competing Ethical Concerns in Combination (Field and Caplan 2008)
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